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Abstract 
This thesis presents three different approaches to enhance crystallization of membrane proteins. The 
major part of the thesis presents the establishment of a method to stabilize membrane proteins by 
mutagenesis. Although it is fairly straightforward to introduce mutations in proteins using random 
mutagenesis, the selection of mutants that are more stable than wild type generally involves exhaustive 
screening. Adding detergent stability as a selection parameter to the thermal stability, this project 
established a generic high throughput screening method using an Escherichia coli sodium-proton 
antiporter NhaA as a model. A screening funnel rapidly eliminated unstable mutants based on their 
expression level, octyl glucoside solubility, and elution profile of fluorescent size exclusion 
chromatography (FSEC), leaving only several mutants to be subjected to rigorous thermal stability 
assay. The screening identified 2 mutants, which exhibited significantly improved thermostability at 
the protein’s active pH of 8.5. The preliminary crystal structure of an NhaA dimer complex is also 
presented. This structure was determined at a resolution of 3.8 Å. Although biochemical studies have 
suggested NhaA exists as a dimer in the lipid bilayer, the only available dimer structure has been a 
cryo-EM model at 7 Å published earlier this year. Overall the two structures are very similar although 
the position of the β-sheet at the dimer interface differs slightly.  
 
Two minor chapters discuss construct engineering and antibody co-crystallization to enhance 
crystallization. Constructs were made for five different P450s involved in biosynthesis of the moulting 
hormone ecdysone from Drosophila melanogaster and Bombyx mori. The null expression under 
different growth conditions suggests the design requires further optimization. Co-crystallization of 
human erythrocyte anion exchanger Band 3 with a Fab fragment of BRAC18 resulted in Fab crystals. 
The Fab crystal structure was determined to a resolution of 1.6 Å with the view of aiding Band 3: Fab 
structure determination.  
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Abbreviations and Nomenclature 
 
  
AE1 Anion exchanger 1 
ALA 5-Aminolevulinic acid hydrochloride 
B. mori Bombyx mori 
β1AR β1 adrenergic receptor 
CaCl2 Calcium chloride 
CD Circular dichroism 
CH Heavy chain constant region 
CL Light chain constant region 
CMC Critical micelle concentration 
CO2 Carbon dioxide 
CoCl2•6H2O Cobalt (II) chloride hexahydrate 
COX Cytochrome C oxidase 
cPCR Colony PCR 
CPM N-[4-(7-diethylamino-4-methyl-3-coumarinyl)phenyl]maleimide 
Cryo-EM Cryoelectron microscopy 
CuCl2•2H2O Copper (II) chloride dihydrate 
CV Column volume 
DG n-Decyl-β-D-glucopyranoside 
DGK Diacyl glycerol kinase 
Dib Disembodied 
DM n-Decyl- β-D-maltopyranoside 
dNTP Deoxynucleotide triphosphate 
DTT Dithiothreitol 
E. coli Escherichia coli 
EDTA Ethylenediaminetetraacetic acid 
epPCR Error-prone PCR 
ESR Electron spin resonance 
FeCl3•6H2O Ferric chloride hexahydrate 
FSEC Fluorescence size-exclusion chromatography 
GFP Green fluorescent protein 
GPCR G-protein coupled receptor 
H3BO3 Boric acid 
HCl Hydrochloric acid 
HCO3- Bicarbonate ion 
His4 tag  4 x His tag 
His8 rag 8 x His tag 
ICL Intracellular loop  
IMAC Metal ion affinity chromatography 
IPTG Isopropyl 1-thio-β-D-galactopyranoside  
LacY Lactose permease 
KPi Potassium phosphate 
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LB media Luria-Bertani media 
LDAO n-Dodecyl-N,N-dimethylamine-N-oxide 
mAb Monoclonal antibodies 
MgCl2 Magnesium chloride 
MgSO4 Magnesium sulphate 
MWCO Molecular weight cut off 
NaCl Sodium chloride 
Na2MoO4•2H2O Sodium molybdate dihydrate 
NG n-Nonyl-β-D-glucopyranoside 
NM n-Nonyl-β-D-maltopyranoside 
NMR Nuclear magnetic resonance 
OD Optical density 
OG n-Octyl-β-D-glucopyranoside 
OmpP Outer membrane protease P 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PEG Polyethylene glycol 
Phm Phantom 
Sad Shadow 
SDS Sodium dodecyl sulphate 
SEC Size-exclusion chromatography 
SE-HPLC Size-exclusion high-pressure chromatography 
Spo Spook 
TB Terrific broth 
TEV protease Tobacco etch virus protease 
v/v Volume per volume 
VH Heavy chain variable region 
VL Light chain variable region 
w/v Weight per volume 
ZnCl2 Zinc chloride 
αDDM n-Dodecyl-α-D-maltopyranoside 
β2AR β2 adrenergic receptor  
βDDM n-dodecyl- β-D-maltopyranoside 
 
 Use of Terminology 
 
  
Thermal Stability 
A measure of how rapidly the protein unfolds at temperatures above its native 
environment.  
 
Kinetic Stability A measure of how rapidly a protein unfolds.   
Detergent 
Stability A measure of how rapidly a protein unfolds in detergent solutions.  
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1.1. Membrane Protein Crystallization 
The function and mechanism of a protein is largely determined by its structure. This highlights the 
important role structure determination plays in various disciplines of life sciences, such as physiology, 
enzymology, and pharmacology. X-ray crystallography, Nuclear Magnetic Resonance (NMR), 
cryoelectron microscopy (cryo-EM), are all vital tools in protein structure determination. The strength 
of X-ray crystallography is in its high resolution and in its applicability to macromolecules. However, 
in order to use this method the protein must first be crystallized.  
 
Crystallization of any compound requires a highly pure and monodisperse sample at high 
concentration. The biochemical characteristics of the protein make it difficult to meet these 
requirements. The need for high purity requires the protein to be sufficiently stable in order to survive 
rigorous purification. Extensive purification is necessary because the protein is normally produced in 
cells. The protein must also be in one conformation and in one oligomeric state (i.e. conformationally 
mondisperse). This requirement is also challenging as proteins are flexible and often exist as equilibria 
between monomers and oligomers in solution. Furthermore, the protein must pack in a regular array 
making specific contacts between different molecules. This is also difficult as proteins are relatively 
large and irregularly shaped. 
 
The basic requirements for membrane protein crystallization (Newby et al. 2009) are the same as 
those for soluble proteins. However, they must first be extracted from the membrane using detergent. 
Their need for detergent extraction, structural flexibility, and relatively small polar surface area make 
meeting these requirements more challenging.  
 
1.2.  Membrane Protein Diversity and Crystallization 
The basic requirements for membrane protein crystallization (Newby et al. 2009) are the same as 
those for soluble proteins. As the name “membrane proteins” implies they are associated with the 
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membrane, which is made of a lipid bilayer. Integral membrane proteins traverse the membrane, but 
peripheral membrane proteins are either associated, enzymatically linked, or anchored to one leaf of 
the membrane. Although some membrane proteins contain large hydrophilic domains, many polytopic 
membrane proteins consist of a large transmembrane region and small hydrophilic loops (Macher & 
Yen 2007). This explains why their extraction usually requires detergent. The amphipathic nature of 
the detergents shields the hydrophobic transmembrane region from exposure to aqueous solution upon 
solubilization, which could lead to protein aggregation or precipitation (Seddon et al. 2004). 
 
Membrane proteins carry out a variety of physiologically important roles such as signal transduction, 
ion and solute transport, energy production, and metabolic reactions of hydrophobic/amphipatic 
substrates. They take advantages of their localization/proximity to the membrane as well as their 
hydrophobicity to perform their functions. The transport of ions and solutes is necessary to allow these 
entities to cross the membrane. Energy production profits from the electrochemical gradients across 
the membrane generated by ion transporters. The metabolic reactions of hydrophobic/amphipathic 
substrates utilize the amphipathic environment created by the lipid bilayer of the membrane. The 
important roles these membrane proteins play make it imperative to determine their structures in order 
to elucidate the complex workings of a cell.  
 
1.3. Brief Introduction of the Projects 
As mentioned in the outset, the crystallization of membrane proteins is challenging. In this work, three 
different approaches to enhance the crystallization have been explored: mutational thermostabilization, 
construct engineering, and co-crystallization of a protein with an antibody Fab fragment.  
 
The second chapter of the thesis, presenting the major part of the work, concerns the development of a 
high throughput method to select thermostabilized mutants of a protein that had been subjected to 
random mutagenesis. The recent structure determination of β1 adrenergic receptor (β1AR) highlighted 
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the potential of mutational thermostabilization on membrane protein crystallization (Serrano-Vega et 
al. 2008; Warne et al. 2008). Although mutational thermostabilization has been used successfully for 
the structure determination of lactose permease (lacY) and β1AR, this approach requires exhaustive 
and lengthy screening of mutants (Guan & Kaback 2006; Warne et al. 2009). The aim of the project 
was to establish a high throughput screening method for thermostabilized mutants using an integral 
membrane protein Escherichia coli Na+/H+ antiporter NhaA as a test case. This chapter discusses the 
efficacy and efficiency of the screening in comparison to the other mutational thermostabilization 
assays. 
 
The third chapter of this thesis presents the crystallization of NhaA and the preliminary structure 
determination of an NhaA dimer complex at its inactive pH of 3.5. This is an extension of the first 
chapter. Hunte et al first published the crystal structure of NhaA at a 3.45 Å resolution in 2005 (Hunte 
et al. 2005). Although NhaA is known to exist as a dimer in the lipid bilayer, the arrangement of the 
molecules in the structure was not consistent with the physiological dimer. Recently the physiological 
dimer structure was obtained by both cryo-EM at a resolution of about 7 Å and pulsed electron 
paramagnetic resonance. The models suggested that the dimerization is mediated by the residues on 
the β-sheet and helices VII and IX (Appel et al. 2009; Hilger et al. 2007). The aim of the project was 
to obtain either better resolution or novel conformation of the structure.  
 
The fourth chapter in this thesis is the construct engineering of a peripheral protein. We were 
interested in solving the crystal structures of four P450 monooxygenases from Drosophila 
melanogaster (fruit fry) and their homologues in Bombyx mori (silk worm). They are involved in  the 
biosynthesis of moulting steroid ecdysone. Insects synthesize ecdysone from dietary cholesterol or 
plant sterol through a multi-step pathway (Brown et al. 2009). Biochemical studies have established 
that the three target proteins, phantom (phm), disembodied (dib), shadow (sad), are involved in the 
terminal oxidation of the synthetic intermediates (Brown et al. 2009). The exact enzymatic role of 
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spook (spo) in the pathway is still unclear, although biochemical studies suggested it may be involved 
in the so called “black box reaction”, the non-elucidated part of the pathway (Namiki et al. 2005) 
(Brown et al. 2009; Rewitz et al. 2006a). As P450s are monotopic proteins, their N-terminal 
membrane anchor region is commonly either deleted or substituted with a hydrophilic sequence to 
enable detergent-free purification. The initial aim of the project was to determine structures of the 
target P450s. This chapter briefly discusses the construct design of the target P450s.   
 
The fifth chapter of the thesis presents the crystal structure of an anti-Band 3 Fab fragment BRAC18 
(Smythe et al. 1995). The ultimate aim of the project was to determine the crystal structure of the 
membrane spanning domain and C-terminal cytosolic domain of Band 3, a human erythrocyte anion 
exchanger. The initial crystals obtained, however, of Band 3 crystallized in the presence of the Fab 
turned out only to contain the Fab fragment. The structure was refined to aid in the structure solution 
of the Band 3 complex should future work produce crystals of Band 3 co-crystallized with this Fab 
fragment. 
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1.  
2.1. Introduction 
2.1.1. Crystallization, Thermal Stability and Conformational Homogeneity  
Many researchers have suggested there to be a correlation between the success of crystallization and 
membrane protein stability (Rosenbusch 2001). As discussed in the previous section, stability is an 
important issue for membrane protein crystallization. Crystallization requires the membranes to be 
solubilized by detergent for purification, which destabilizes protein (Rosenbusch et al. 2001) (Zhou et 
al. 2001a). In essence, membrane proteins are not optimized to remain folded in a detergent micelle. 
This gives us a tantalizing prospect of enhancing the stability by protein engineering. The recent 
structure determination of the G-protein coupled receptor (GPCR) β1 adrenergic receptor (β1AR) 
underscores the possibility. β1AR was stabilized by mutation and truncation. The authors 
systematically mutated the protein using alanine scanning to identify thermally stabilizing mutations 
in detergent solution. The combined mutations raised the melting temperature by 21 °C, as measured 
by a ligand binding assay (Serrano-Vega et al. 2008). The thermal stability measured here is a kinetic 
stability of the protein, or the stability against unfolding.  
 
In addition to thermal stability, conformational homogeneity has a strong impact on protein 
crystallization (Huber et al. 2007; Magnani et al. 2008). Many proteins have flexible loops and 
termini. The flexibility allows proteins to shift between multiple confirmations, which are essential to 
their functions (Kaltashov & Eyles 2002; Langosch & Arkin 2009). For example, ligand versatility of 
GPCRs depends on the co-existence of multiple conformations. Binding of a particular ligand 
stabilizes a particular conformation, which leads to a unique reaction pathway (Rosenbaum et al. 
2009). In case of the NhaA, a sodium-proton antiporter, the transport of ions across the membrane is 
accompanied by conformational changes induced by sodium ion binding (Appel et al. 2009).  
 
Although conformational heterogeneity is important for membrane protein function, it could hinder 
crystallization (Huber et al. 2007). Conformational thermostabilization could enhance conformational 
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homogeneity by increasing the kinetic stability of particular conformation (Magnani et al. 2008). It is 
possible that the conformational homogeneity and kinetic stability of a protein are related (Zhou & 
Bowie 2000). This was seen in thermostabilization of lactose permease (lacY). Wild type lacY is 
kinetically unstable and conformationally heterogeneous. It rapidly aggregates in detergent, and 
fluctuates between inward-facing and out-ward facing conformations and associated sub-
conformations (Guan & Kaback 2006; Nie et al. 2006). Introduction of point mutation C154G not 
only kinetically stabilized lacY, but also locked the protein into an inward-facing conformation, 
facilitating structure determination (Abramson et al. 2003; Guan & Kaback 2006; Smirnova & Kaback 
2003).  
 
2.1.2. Thermostabilization by Random Mutation 
Encouraged by the structure determination of β1AR, we wished to investigate whether we could 
generate a general method for stabilising membrane proteins through mutagenesis. In this project, we 
decided to mutate the protein randomly as opposed to systematically as performed for β1AR, (Serrano-
Vega et al. 2008) because mutational stabilization is not always predictable (Serrano-Vega et al. 
2008). Unfolding studies of native and mutant proteins suggest that the kinetic stability of protein is 
affected by many internal and external factors, such as mutation, temperature, salts, and ligand binding 
(Janovjak et al. 2008; Sapra et al. 2008). The unpredictability of mutational stabilization can be 
visualized by using an energy landscape of a protein (Hilser et al. 2006). The landscape consists of 
wells of native conformations and intermediates to protein unfolding, and ridges of energy barriers 
that must be overcome in order to shift from one conformation/intermediate to another (Sapra et al. 
2008). A mutation may change the height/location of a single ridge. The change may be moderate and 
local, but it could affect global contour lines of the energy landscape of the protein.  
 
Importantly, thermostabilization of β1AR suggests the stability is not just related to the screening 
parameters used in the stability optimization process, but correlates well to other destabilizing 
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conditions. In their experiment, thermally stabilized mutants were also detergent stabilized. This has a 
direct impact on protein crystallization, as short chain detergents are more suited for crystallization. 
The relationship between crystallization and detergent chain length will be discussed in methodology 
section in more detail. The correlation between the thermal stability to other destabilizing factors 
broadens the selection of screening parameters for stability assays to other destabilizing factors, such 
as detergents and pH (Serrano-Vega et al. 2008). 
 
2.1.3. Rate of Stabilizing Mutation 
It is clear from both theoretical and experimental considerations that the introduction of mutations can 
lead to the stabilization of membrane proteins. However, the rate of stabilizing mutations could affect 
the practicality and feasibility of mutational stabilization. One estimate drawn from mutational studies 
of the transmembrane segment of the M13 coat protein, the transmembrane segment of diacyl glycerol 
kinase (DGK), and the Kcs K+ channel puts the percentage of stabilizing mutation of membrane 
protein to be around 10 %, which is significantly higher than that of soluble proteins (Bowie 2001).  
The structural flexibility of membrane proteins may explain the reason for the difference (Bowie 
2001).  Biological functions and activity mechanism of membrane protein favour flexible and mobile 
structure. This implies substitution mutation could be accommodated with little change in local 
structure. Extensive mutagenesis of lacY and STE2, an yeast GPCR, revealed these membrane 
proteins exhibited high tolerance toward sequence changes (Mackenzie 2006). Kaback and colleagues 
performed Cys-scanning mutagenesis over entire lacY molecule, and generated a population of Cys-
less mutants. They found the majority of them were functional (Frillingos et al. 1998). Similarly 
random mutagenesis of STE2 found every residue in the seven transmembrane helices tolerated 
hydrophobic substitutions and 73 % of them tolerated polar substitutions while showing some level of 
activity (Martin et al. 2002). 
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The rate of beneficial mutations could even be higher than 10 %, as mutations that may not improve 
stability could enhance crystal packing. For instance, mutations in surface area that reduces side chain 
entropy (i.e. Substitution to smaller amino acid residues) could facilitate crystal contact formation 
(Cieslik & Derewenda 2009). Even a point mutation may be beneficial. The analysis of 821 soluble 
protein structures found that close to a half of all the crystal contacts were small-sized, four amino 
acid residues or less (Cieslik & Derewenda 2009). The same principle seems to apply to membrane 
protein crystallization, as a simulation study of outer membrane protease P (OmpP), a β-barrel 
membrane protein suggested K107Y mutation at loop L3 strengthened crystal contact between L3 and 
turn T2 (Bond et al. 2006; Pautsch & Schulz 2000). In addition mutations that facilitate 
oligomerization could enhance the packing by generating repeated crystal contacts along the lattice (W 
Nicholson Price II 2008). With this relatively high rate, it is feasible to design and implement high 
throughput mutagenesis and screening in order to enhance crystallization. 
 
2.1.4. Methodology 
In this project, we aimed to establish a high throughput method to generate and identify thermo-
stabilizing mutations. As discussed in the previous section, we chose a random mutagenesis approach, 
which allows us to generate library of mutants in a short time. The bottleneck of such an approach is 
often the screening of mutants. We designed a high throughput screening-funnel in order to quickly 
identify thermostabilizing mutations in the library (Figure 2.1). The funnel is designed to eliminate 
constructs unlikely to be stable using rapid assays at the start of the process, and to require purified 
protein only at the last step.  
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2.1.4.1. Mutagenesis 
The key point of this step was how to generate a mutant library.  In silico mutagenesis could identify 
potential mutation hot spots from a structure model built from primary sequence or homologue, and 
various substitution mutants can be generated for screening (DeLano 2002). A few on-line servers are 
available for sequence scanning, including the Robetta server (Kim et al. 2004) and ProtScale tool of 
the ExPASy proteomics server (Grantham 1974). The drawback of a bioinformatic approach is that it 
may miss potentially beneficial mutations. A study on bacteriorhodopsin helix B revealed that in silico 
mutagenesis could not identify all the thermal stability hot spots (Faham et al. 2004). Systematic 
mutagenesis is probably the most unfailing method, but it is also exhaustive. A thermostable lacY 
C154G mutant was identified through Cys-scanning mutagenesis of the entire molecule. In contrast, 
random mutagenesis is fast and capable of identifying both “predictable” and “unpredictable” 
mutation hot spots. The method has been used to generate thermostable mutants in DGK (Zhou & 
Bowie 2000). The mutagenesis yielded a quadruple mutant with a half-life 18 times longer than the 
wild type at 80 °C. 
1. Mutagenesis 
2. Expression Screening 
3. OG Solubility Screening 
4. FSEC 
5. Sequencing 
6. Purification 
7. Thermal Stability Assay 
 
 
 
 
 
 
 
Figure 2.1 Schematic Diagram of a Screening Funnel 
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The second important point is what mutation frequency to use. The optimal mutation frequency is 
difficult to judge. For structural analysis, the conservation of the wild type structure while generating 
diverse library is desirable. Low mutation rates generate genes that are more likely to retain wild type 
function, but contain less unique sequences. High mutation rates (15 - 30 mutations per gene) generate 
mostly unique sequences, but few retain wild type function (Drummond et al. 2005). While initial 
mutagenesis of β1AR generated many point mutants, researchers noted a combination of distal 
mutations tended to produce greater effects (Serrano-Vega et al. 2008). Similarly generation of DGK 
mutants with multiple mutation sites enabled researchers to identify hot spots by comparing mutations 
(Zhou & Bowie 2000). 
 
For this project we selected to carry out random mutagenesis with a mutation frequency of 1 - 3 
mutation sites per mutant. Random mutation was chosen for its speed and indiscriminateness. In order 
to minimize any sequence bias, an error-prone PCR system that shows low sequence bias against As 
and Ts was used to generate the library. The mutation frequency chosen was intended to conserve the 
wild type structure while leaving room for stabilization by distal interactions.       
 
2.1.4.2. Mutant Screening 
The keys to this step are the choice of screening parameter, sample type, and detection method. In 
principle, any parameter that destabilises protein structure can be used to assess mutant stability 
(Serrano-Vega et al. 2008). Thermal stability was used for several GPCRs (Magnani et al. 2008; Roth 
et al. 2008; Serrano-Vega et al. 2008), and stability in short chain detergents was used for DGK (Zhou 
& Bowie 2000). These parameters could be built into assays that are applicable to both solubilized 
membrane and purified protein.  
 
The choice of sample type determines whether a screening is exhaustive or rapid. Commonly used 
sample types are whole cells, solubilized membrane, or purified protein samples. Untreated whole 
 22 
cells are the easiest to use, but expression level enhancement of a GPCR required a fluorescently 
labelled ligand (Sarkar et al. 2008). Similarly thermostabilization assays carried out in detergent 
solubilized cells required the use of high-affinity ligands (Magnani et al. 2008; Zhou & Bowie 2000). 
Membrane samples are relatively easy to prepare, but it gives high rate of false positive. The initial 
thermal stability assay of β1AR used detergent solubilized membrane, and calculated error rate was 
about 10 % (Serrano-Vega et al. 2008). Purified protein gives lower error rate (Serrano-Vega et al. 
2008), but it is exhaustive and costly to prepare. 
 
A direct and specific detection method is highly desirable for any assay. Stability assays of GPCRs 
and DGK used ligand binding or enzymatic activity to measure the target protein activity (Magnani et 
al. 2008; Serrano-Vega et al. 2008; Zhou & Bowie 2000). The drawback of this detection method is 
that it is not universally applicable. For instance, it is technically challenging to assay the transport 
activity of channels and transporters. The need for labelled ligands or inhibitors (Prive 2007) restricts 
its application. Assays that measure the degree of protein unfolding, such as calorimetry, circular 
dichroism (CD), thermal stability assay using a fluorescent dye, are universally applicable. However, 
they are not target protein specific and batch-dependant sample purity may influence the results. In 
addition, calorimetric measurement is strongly influenced by detergent (Minetti & Remeta 2006) and 
lacks accuracy owing to partial unfolding of proteins (Renthal 2006). 
 
Thermal stability assays using fluorescent dyes are universally applicable, but they require purified 
protein. This type of assay was first developed for soluble proteins, such as an assay using Sypro 
Orange (Ericsson et al. 2006; Vedadi et al. 2006). Recently an equivalent assay for membrane protein 
was developed using a fluorescent dye N-[4-(7-diethylamino-4-methyl-3-
coumarinyl)phenyl]maleimide (CPM) (Alexandrov et al. 2008). As CPM interacts with internal thiol 
groups of membrane proteins, the assay can be used for any membrane protein with an internal thiol 
group. The drawback of the CPM assay is that it has limited pH range of 6 to 8. 
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A few size-exclusion chromatography based stability assays have been used for membrane proteins. 
Fluorescence size-exclusion chromatography (FSEC) is capable of assessing monodispersity and 
giving some indication of the stability of the protein under the conditions of the experiment (Drew et 
al. 2008). Size-exclusion high-pressure chromatography (SE-HPLC) is used to detect time-dependant 
aggregation (Prive 2007). The limitation with a chromatographic approach is that the assay is 
qualitative rather than quantitative. Although it can eliminate conditions or mutants that are 
destabilizing, it is difficult to quantitatively differentiate stabilized mutants that display equally 
monodispersed profiles. 
  
2.1.4.3. Octyl Glucoside (OG) Solubility Efficiency Assay 
We decided to base the initial high-throughput screening parameter on detergent stability of a 
membrane protein, or more specifically, on the solubilization efficiency in the detergent octyl 
glucoside (OG). OG is a harsh detergent that does not retain aggregated material in solution.  We have 
empirically found OG solubilization rates to be an informative indicator of detergent stability, in 
contrast to many other detergents such as n-dodecyl-β-d-maltoside (DDM) or dodecyldimethyl-N-N-
dimethylamine (LDAO)  (our unpublished observations). 
 
OG solubility screening is designed to select for mutant proteins that are more stable than the wild-
type protein in detergent solution. The assay is similar to the method by Zhou and colleagues (Zhou & 
Bowie 2000), but it uses different type of sample and detection method. They used OG solubilized 
whole cell, but this assay uses membrane sample, same as the thermal stability assay of β1AR 
(Serrano-Vega et al. 2008). This assay uses fluorescent count of a C-terminal GFP tag for rapid 
screening, instead of enzymatic activity used for the thermostabilization of DGK. The advantage of 
this OG solubility assay is its universal applicability to any membrane proteins (Drew et al. 2006; 
Drew et al. 2001).  
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The relative harshness of detergent is 
determined by mainly two factors: its 
solubilization power and micelle size. 
Solubilization power lies in its head group. It is 
the strength to disrupt protein-protein, protein-
lipid, and lipid-lipid interactions. Zwitterionic 
detergents are capable of disrupting all three 
interactions. In contrast, non-ionic detergents 
disrupt mainly lipid-lipid and protein-lipid 
interactions. The second factor, micelle size, is 
determined by the molecular size. The Stokes 
radius of the detergent micelle decreases by 3.1 
Å for every carbon removed from the alkyl 
chain of alkyl-maltosides (Kunji et al. 2008). 
Although both OG and DDM are non-ionic 
detergents, DDM (12C) is mild and widely used 
for membrane protein solubilization (Seddon et 
al. 2004) whereas OG (8C) precipitates many 
membrane proteins. LDAO is a zwitterionic 
detergent, capable of solubilizing majority of 
membrane proteins. 
 
The micelle size matters as it replaces the lipid bilayer upon the detergent solubilization of membrane. 
Membrane proteins are composed of a hydrophobic core sandwiched by polar surfaces (Figure 2.2). 
In the membrane, the hydrophobic core interacts with the hydrophobic tail, and polar surfaces with 
 
Figure 2.2. Membrane Proteins in Lipid 
Bilayer and Detergent Micelle Taken from 
Sansom et al (Sansom et al. 2005) 
A. Protein in lipid bilayer. w: water, i: 
interface, h: hydrophobic core. 
Yellow sphere is polar headgroup 
of lipids, and black line is 
hydrophobic alkyl chain  
B. Protein in Detergent Micelle. Red 
sphere is polar headgroup of 
detergents, and black line is 
hydrophobic alkyl chain 
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polar headgroup of the lipid. Detergents extract membrane proteins from the lipid bilayer and package 
them into individual detergent micelles. As the detergent has a similar molecular makeup to lipid, the 
detergent headgroup replaces the lipid headgroup, and the detergent tail does likewise. The micelle 
allows the hydrophobic region of the membrane protein to remain in a hydrophobic environment. Thus 
the membrane proteins are more stable in the detergent micelle which diameter of hydrophobic core 
and thickness of the hydrophilic headgroup closely match its length of hydrophobic region and 
hydrophilic region. 
 
2.1.4.4. Fluorescence Based Size-Exclusion Chromatography (FSEC) 
Mutant stability and monodispersity in 
DDM and LDAO was assessed in this assay. 
In brief, detergent solubilized membrane 
was subjected to size-exclusion 
chromatography. The fractions of elute were 
collected in 96-well and volume-resolved 
elution curve of mutants were drawn based 
on the GFP fluorescent. The aim of this 
assay is to eliminate mutants that are 
polydispersed, highly unfolded, or 
destabilized. Figure 2.3 is a hypothetical 
FSEC elution curve. When using a Superose 6 10/300 column, the GFP-tagged protein is eluted 
around 15 ml. The first small peak in a void volume is from aggregated protein. The second peak is 
from GFP-tagged protein, and the third is from proteolyzed free GFP. If the GFP-tagged protein 
elution peak is branched, the protein is polydispersed. The symmetry and peak width of GFP-tagged 
protein is an indicator of the stability of the protein in the detergent used. A high peak corresponding 
to free GFP is an indication of unfolding as unfolded protein is susceptible to proteolysis.  
 
Figure2.3. Hypothetical FSEC Elusion 
Curve 
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The advantage of the FSEC assay is that it requires only a small amount of detergent solubilized 
membrane. This is a great timesaving as it eliminates the need to purify the mutant protein. A 
shortcoming of the assay, as previously highlighted, is that it is not quantifiable and interpretation is 
rather subjective.  
 
2.1.4.5. Microscale Thermal Stability Assay by CPM 
The aim of this assay is to measure stability of mutants in various detergents. A small amount of 
purified protein sample was diluted in various buffers. For NhaA, the model protein used in this 
method development, differing pHs were also included in the experimental parameters as the protein 
has a pH sensitive activity profile. Fluorescence emitted by thiol-bound CPM was used to measure 
time-resolved unfolding of mutant proteins. A one-phase decay curve was fitted to the calculated 
decay curve from the measurement assuming the highest fluorescent count as 100 percent unfolding.  
The half-life of the mutant at each condition was calculated from the fitted one-phase decay curve. 
 
By comparing the CPM assay data to melting curves measured by CD, we found a clear correlation 
with half-life stability and melting temperatures (unpublished data). Under the parameters used in the 
assay (40 ℃ for 140 minutes) the relationship is linear from an unfolding rate of 16 minutes up to 75 
minutes. A half-life of 75 minutes corresponds to a melting temperature of 60 ℃. A half-life of more 
than 75 minutes the conditions are not destabilizing enough to accurately measure unfolding rates, and 
therefore, the assay cannot distinguish the stability differences between samples with half-life longer 
than 75 minutes. A half-lie of less than 16 minutes the membrane protein has aggregated in this 
detergent solution at room temperature (as evaluated by SEC for 30 different membrane proteins).  
 
Although we could increase the temperature to give more accurate unfolding rates for samples that 
have a half-life greater than 70 minutes, we substantially increase the fraction of samples that have a 
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half-life of less than 16 minutes, which is problematic since we lose data for most of the membrane 
proteins monitored in the harsher detergents. Our analysis from comparing the stability differences 
between 30 membrane proteins, for which we were able to crystallize, suggests that accurately 
monitoring stability in harsher detergents is more informative than stability under mild conditions.  
 
Taken these considerations together, we have empirically found that conditions for which the majority 
of membrane proteins fall into this working range (half-life of 16 to 75 minutes) is the best 
compromise for comparing membrane protein stability in a range of different detergents. The 
advantages of this assay are its ease of use and small amount of protein required. Once the protein 
sample and a dye are added to the buffer, a plate reader automatically measures the fluorescence 
count. Only 1 – 20 µg protein sample per condition is required for assay (Alexandrov et al. 2008). 
 
2.1.5. Model system: Escherichia coli Sodium-Proton Antiporter NhaA 
In this project, an E. coli Na+/H+ antiporter NhaA was used as a test case. NhaA belongs to a family of 
Na+/H+ antiporters that regulate the concentration of cytosolic sodium ion and proton (Padan et al. 
2004). These concentrations are tightly regulated in all living cells, and Na+/H+ antiporters are 
universally found both in prokaryotes and eukaryotes (Padan 2001). Since protein function is pH 
dependant, pH homeostasis is especially vital to cell survival. In prokaryotes, the antiporters confer 
survival in high pH and salinity (Padan 2001). In humans, they are involved in heart diseases, cell 
growth and cell differentiation, in addition to homeostasis of sodium ion and pH (Kemp et al. 2008). 
 
As shown in Figure 2.4, E. coli has an intricate web of ion concentration regulation systems (Padan et 
al. 2005). NhaA is the primary Na+/H+ antiporter of E. coli (Padan et al. 2004; Padan 2001), and NhaA 
is vital to the cell growth in alkali pH (Padan et al. 2004). NhaA transports Na+, Li+ and H+, and 
stoichiometry of the transport is 1 Na+/Li+: 2 H+. The activity of NhaA is regulated by cytosolic pH. It 
is activated at around pH 6.5, reaches maximum activity at pH 8.5, and is still active at pH 9 (Padan et 
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al. 2004). NhaA exists as a dimer in the native 
environment although monomer is fully 
functional (Gerchman et al. 2001) (Hilger et 
al. 2005). Study of a dimerization-deficient 
mutant suggests the dimerization may 
essential for stability at the conditions that 
require maximum activity (Rimon et al. 2007).  
 
NhaA is chosen as a model protein for its high 
expression and propensity to crystallize. 
Furthermore, the protein has been thoroughly 
biochemically characterized and its structure is already known. These previous studies allow us to rely 
on these experiments for functional characterization to speed up the project. 
 
2.2. Aim 
The ultimate aim of the project was to generate a generally applicable detergent-stabilization 
mutagenesis approach that could be applied to stabilize many of the eukaryotic membrane proteins. 
These proteins are intrinsically less stable in detergent solution than bacterial membrane proteins, a 
characteristic that has hindered their structural determination (Drew & al.). 
 
The benchmarks we initially aimed to achieve were: to obtain 10-20 clones that have greater than 50 
percent solubilization efficiency in 4 % w/v OG, to eliminate false-positive by FSEC, to purify these 
candidate mutants and measure their stability in solution using the CPM assay. The final goal would 
be to generate a few significantly thermostabilized mutants that could be used for crystallization of the 
active form of the protein, or of the inactive form of the protein at a higher resolution than was 
originally reported.  
Figure 1.8. Proposed Transport 
Mechanisms of Na+/H+ Transporter, 
NhaA 
A. Arkin et al (Arkin et al. 2007) 
B. Hunte et al (Padan et al. 2009) 
 
Figure 2.4. Sodium and Proton 
Concentration Homeostasis Mechanism 
in E. coli Taken from Padan et al. (Padan 
et al. 2005)  
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2.3. Materials and Methods 
Restriction enzymes were purchased from New England BioLab (Ipswich, MA, USA). DNA 
purification kits were from Promega (Southampton, Hampshire, UK), and all gels for DNA and 
protein analysis were from Invitrogen. All detergents were purchased from Anatrace (Maumee, OH, 
USA) and chemical reagents were from Sigma-Aldrich unless specified otherwise. Pre-packed 
chromatographic columns were from GE Healthcare (Bucks, UK). Unless specified, DDM used was a 
β isomer. The wild type NhaA expression vector NhaA-pWaldo-GFPe and vector pWaldo-GFPe was 
a kind gift from Dr. David Drew of Imperial College London. 
 
2.3.1. Mutagenesis 
Mutants were generated by error-prone PCR (epPCR) using either the expression plasmid or a PCR 
product of the gene using GeneMorph II Random Mutagenesis Kit (Stratagene) according to supplier’s 
direction. The gene fragment was generated by standard PCR using AccuPrime Pfx (Invitrogen). The 
same primer pair, forward primer 5’-CGC CGC CTC GAG ATG AAA CAT CTG CAT CGA TTC 
TTT AG-3’ and reverse primer 5’-GCG GCG GAA TTC AAC TGA TGG ACG CAA ACG AAC 
GCG-3’, was used for both standard and epPCR. Mutant PCR products were double digested with 
XhoI/EcoRI, and cloned into sequentially digested vector pWaldo-GFPe using Rapid DNA Ligation 
Kit (Roche). Mutant plasmids were transformed into Top10 competent cells (Invitrogen), and 
individual colonies were analysed by colony PCR (cPCR) to examine whether they carried the insert. 
Later cPCR was omitted as several experiments confirmed almost a hundred percent of the colonies 
carried the insert. At cPCR setup, minute amount of cells from a colony were transferred to a grid-
lined plate to give an ID, and to a 10-µl aliquot of cPCR reaction mixture by a sterilized toothpick. 
Stock cPCR reaction mixture contained 100 mM dNTPs (Promega), 1.5 mM MgCl2, 250 unit/ml of 
aTaq DNA Polymerase (Promega), and 10 mM each of primers 5’-TAA TAC GAC TCA CTA TAG 
GG-3’ and 5’-GAA AAG TTC TCC TCC TTT GC-3’. cPCR products were examined using 1.2 % E-
gel with Syber-Safe for the presence of a strong band at around 1.2 kbp. Mutant plasmids were 
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harvested from a 5 ml overnight culture grown at 225 rmp, 37 ℃. The plasmids were purified using 
Mini-Prep Kit and stored at room temperature.  
 
The mutation frequency of epPCR is controlled by the concentration of the template gene, and the 
optimum gene concentration needs to be determined experimentally. The percentage of mutants in a 
library was estimated from the expression level of around 20 colonies. Any constructs with markedly 
different expression level were assumed to be mutants, as wild type expression level was fairly 
constant. Around five assumed mutants per library were sequenced to estimate the mutation 
frequency. The template gene concentration was optimized until the library contained more than 
eighty percent of constructs carrying 1 - 3 mutations. 
 
2.3.2. NhaA-GFP Expression Screening 
The overall experimental flow is summarized in Figure 2.5. The expression of constructs was 
evaluated in whole-cells by fluorescence generated by the C-terminal GFP tag, as GFP only folds and 
becomes fluorescent if the upstream protein integrates into membrane (Drew et al. 2001). Any 
constructs expressing less than 1mg protein per litre were eliminated, as this was considered the 
minimum expression level that would yield suitable levels for screening. Expression trials were 
carried out in the host strain BL21(DE3) with the pLysS plasmid. The pLysS plasmid is important for 
screening as it encodes for lysozyme to inhibit any leaky expression by endogenous activation of the 
T7 promoter. In general these cells give more reproducible results, although they may not give the 
highest-level of expression. 
Florescence 
Measurement 
Host Change 
(pLys) 
Small-scale 
Expression 
In-gel 
Fluorescence 
Mutation Rate 
Estimation 
Sequencing 
Figure 2.5. Experimental Flow Chart of Expression Screening 
The step in blue font was later omitted. 
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Mutant proteins were expressed as described (Drew et al. 2006). In brief, an inoculum was prepared 
by growing 1 ml culture in 1.5 ml standard test tubes at 225 rpm, 37 ℃ overnight. A 50−µl aliquot of 
the overnight culture was then used to inoculate 5 ml LB media supplemented with antibiotics 
kanamycin (50 µg/ml final concentration)/chloramphenicol (34 µg/ml final concentration) in 50 ml 
Falcon tube, and incubated at 225 rpm, 37 ℃. The temperature was lowered to 25 ℃ at an OD600 of 
about 0.4, and expression was induced at an OD600 of about 0.6 with 0.4 µM isopropyl 1-thio-β-D-
galactopyranoside (IPTG, Melford) final concentration. The inoculation and induction of large number 
of constructs (up to 50 - 60) were synchronized by carrying out all manipulations in clean bench to 
speed up the procedures. Cells were harvested after 16-hour incubation by centrifugation at 3, 000 × g 
for 10 minutes using a benchtop centrifuge. The cell pellet was resuspended in 500 ml PBS (pH 7.6), 
and a 100 µl aliquot was transferred to a black 96-well optical-bottom plate (Nunc). The whole-cell 
GFP fluorescence was measured using a plate reader (Molecular Devices) with an emission of 512 nm 
after exciting at 485 nm. The same setting was used to measure GFP fluorescence of any types of 
samples, whole cell, membrane, or partially purified GFP-fusion protein. The yield of GFP (fused to 
NhaA) was calculated as 
 
{(GFP count) × 1.5 (damping factor) × 2.5 × 10-6 (mg protein/ml)} × elute volume (ml) 
 
The GFP count is the measured intensity of GFP emission, which linearly correlates to the GFP 
concentration of a sample. The damping factor was added to account for dampening of the 
fluorescence in viscous whole cell sample. The number was empirically determined for this GFP in E. 
coli. The conversion factor to the amount of protein was likewise determined from calibration curve of 
purified GFP-His8 (Drew et al. 2006). This could be converted to the amount of target protein by 
multiplying the amount by the fraction of the target protein over GFP (molecular weight of the target 
protein ÷ molecular weight of GFP = 28 kDa) (Drew et al. 2006). 
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In order to examine whether the whole cell GFP count correlates with target protein expression levels, 
the whole cell sample was solubilized and analyzed by SDS-Page (in-gel fluorescence). The whole 
cell sample was solubilized by the addition of 12.5 mg/ml DNase (Novagen) and 10 mM MgCl2 final 
concentrations. After a 5 minute-incubation at room temperature, equal volume of solubilization 
buffer (0.2 M Tris-HCl, pH 8.8/ 20 % v/v glycerol/ 5 mM EDTA, pH 8.0/ 0.02 % w/v bromophenol 
blue/ 4 % SDS/ 0.05 M DTT) was added to the sample, and the sample was incubated for further 4 
minutes at 37 ℃. The solubilized sample was analyzed by SDS-Page using 12 % Tris-Glycine gel 
(Invitrogen). The gel was run for 1 hour and 45 minutes with fluorescent molecular marker 
(Invitrogen), and visualized using UV-VIS detector LAS3000 (Fuji Film). NhaA-GFP protein band is 
found around 40 kDa, and GFP-His8 protein around 20 kDa. This step was later omitted as several 
experiments confirmed that the GFP count correlated with the expression level of the mutant protein. 
 
2.3.3. Detergent Stability Screening 
2.3.3.1. Membrane Sample Preparation 
A 300 ml-culture of mutants were expressed in 500 ml Erlenmeyer flask as described (Drew et al. 
2006). The OD600 of overnight cultures were normalized by dilution in order to synchronize the 
expression induction. The OD600 and the whole cell GFP count of 1ml aliquot were measured at 
harvest. Cells resuspended in ice-cold 20 ml PBS (pH 7.6) supplemented with a minute amount of 
bovine DNase (Invitrogen) and 1 mM MgCl2 final concentration, and lysed using a cell disruptor  
(Constant Systems) (two passages, 25, 000 psi). Yield was improved by washing twice with 10 ml 
PBS. Cell debris and unlysed cells were removed by centrifugation at 10, 000 × g for 10 minutes using 
floor top centrifuge. The supernatant was then centrifuged at 41, 000 × g for 1 hour using a floor top 
ultracentrifuge to pellet down membrane fraction. The membrane was rinsed twice with 2 ml ice-cold 
PBS and resuspended to 2 - 3 ml PBS. 0.5 - 1ml aliquots were snap-frozen in liquid nitrogen, and 
stored at -80 ℃ until use. Total protein concentration and NhaA concentration of membrane sample 
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were calculated using the BCA assay (Pierce, Cramlington, Northd, UK) and GFP count of a diluted 
sample. 
 
2.3.3.2. Octyl Glucoside (OG) Solubilization Efficiency Assay 
The efficiency of solubilization in DDM and OG was measured in triplicates of 1 % w/v DDM and 2 
and 4 % w/v OG final concentrations. To measure the solubilization efficiency the total protein 
concentration was normalized to 4 mg/ml by dilution with PBS. The normalization is essential for an 
accurate solubilization efficiency measurement. A 1.5-ml aliquot was prepared as a working stock, 
and three 1.5 ml test tubes were pre-cooled on ice. An aliquot of 0.4 ml stock membrane sample was 
pipetted into each test tube and either 50 µl of 10 % w/v DDM, 50 µl of 20 % w/v OG, or 100 µl of 20  
% w/v OG detergent stock solution was added to each tube. The final volume was adjusted to 0.5 ml 
with PBS. Samples were vortexed and incubated at 4 ℃ for 1 hour with mild agitation. After 1-hour 
incubation samples were again vortexed and a 100-µl aliquot was removed to measure the GFP count 
(t0 value). The samples were centrifuged at 41, 000 × g for 45 minutes with a bench top centrifuge to 
remove precipitated protein and unsolubilized membrane. The supernatant was transferred to new 1.5 
ml tubes and vortexed, and a 100-µl aliquot was removed to measure GFP count (t45 value). 
Solubilization efficiency was calculated by dividing GFP t45 by GFP t0. The solubilization efficiency in 
OG was measured at two concentrations, and several runs were performed on different days until the 
difference in efficiency between runs was reduced to about 10 % or less. Constructs that were 
solubilized to less than 50 % in 4 % OG were eliminated from further screening. Solubilization in 
DDM was used as a positive control of membrane solubilization. 
 
2.3.4. Fluorescence Size-exclusion Chromatography (FSEC) of Solubilized Membrane 
The experiment was run either independently or concurrently with OG solubilization efficiency assay. 
Membrane samples were either freshly prepared from 2 – 3 L culture or were taken from the samples 
prepared for the solubilization assay. The experiment was carried out mostly as described (Drew et al. 
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2008). The total protein concentration was normalized to 4 mg/ml, and sample was solubilized in 
either 1 % w/v DDM or LDAO as done in the OG solubilization efficiency assay. A 200-µl aliquot of 
solubilized membrane was loaded onto a Superose 6 10/300 GL column equilibrated with a buffer (20 
mM Tris-HCl, pH 7.5/ 0.15 M NaCl/ 0.03 % w/v DDM). After 0.3 column volume (CV), 100 µl 
fractions were collected row-by-row into a black MicroWell 96-well optical bottom plate. The GFP 
fluorescence of each well was measured using a plate reader and plotted against fraction number. 
Constructs were eliminated from further screening if they showed: an aggregation peak; multiple 
peaks; asymmetrical peaks; a high free GFP peak or a broad peak from the samples solubilized in 
LDAO. 
 
2.3.5. Protein Sample Preparation 
2.3.5.1. Membrane Solubilization and First IMAC: Ni-NTA 
The overall flow of the experiment is summarized in Figure 2.6. Membrane was harvested from 3 - 5 
L culture and stored at -80 ℃ until use. Protein purification followed a published protocol (Drew et al. 
2006) with some modifications. The purification was composed of six steps: 1) membrane 
solubilization, 2) initial purification using immobilized ion affinity chromatography (IMAC), 3) GFP 
cleavage and dialysis, 4) a second IMAC column, 5) sample concentration and buffer exchange, and 
6) size-exclusion chromatography (Figure 2.6). The thermal stability of the GFP-tagged protein was 
measured after the first IMAC in order to measure the relative stability of the mutant protein in the pH 
 
Figure 2.6. Protein Purification Experimental Flow Chart 
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range of ~4 to 8. The results were utilized to fine-tune the remaining purification protocol according to 
their stability. The membrane was solubilized in a buffer (PBS, pH 7.6/ 0.15 M NaCl/ 0.02 M 
imidazole, pH 7.5/ 10 % v/v glycerol/ 1 % w/v DDM) at 4 ℃ for 1 hour with constant stirring.  
 
About 1 ml Ni-NTA resin (Qiagen) per mg GFP (calculated from the fluorescent value of membrane 
sample) was equilibrated with the wash buffer A (PBS, pH 7.6/ 0.1M NaCl/ 20 mM imidazole, pH 
7.5/ 10 % v/v glycerol/ 0.03 % w/v DDM) and incubated with solubilized membrane at 4 ℃ for 2 
hours with constant stirring. The resin was washed with 20 CV each of the wash buffer A and the 
wash buffer B (PBS, pH 7.6/ 0.1M NaCl/ 40m M imidazole, pH 7.5/ 10 % v/v glycerol/ 0.03 % w/v 
DDM). GFP-tagged NhaA was eluted with an elution buffer (PBS, pH 7.6/ 0.1 M NaCl/ 0.25 M 
imidazole, pH 7.5/ 10 % v/v glycerol/ 0.03 % w/v DDM). The first ½ CV of the elution was discarded 
and the next 3 CV of the elution was collected. A 300-µl aliquot of elute was set aside for the thermal 
stability assay. A 100-µl aliquot was removed from the flow through and elute in order to calculate the 
binding efficiency and the yield. 
 
2.3.5.2. GFP Cleavage 
His-tagged TEV protease was added to the elute in a mass ratio of 2:1 to the GFP and mixed well. The 
mixture was transferred to a 3350 MWCO Spectra/Por dialysis membrane tube (Spectrum 
Laboratories, Rancho Dominguez, CA, USA), and dialysed at 4 ℃ overnight in 100 times volume of 
dialysis buffer (20 mM MES, pH 6.5/ 0.15 M NaCl/ 1 mM DTT/ 10 % v/v glycerol/ 0.017 % w/v 
DDM).  
 
2.3.5.3. Second IMAC: HisTrap and Buffer Exchange 
Dialyzed and GFP-cleaved sample was centrifuged at 3, 000 × g for 10 minutes to remove any 
precipitation. The sample was loaded onto a 5-ml HisTrap HP column equilibrated with wash buffer 
(0.1 M MES, pH 6.5/ 0.15 M NaCl/ 25 mM imidazole, pH 7.5/ 10 % v/v glycerol/ 0.03 % w/v DDM) 
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using a syringe. The column was washed with 10 CV of the same buffer. If the thermal stability assay 
indicated a mutant was unstable, the wash volume was either halved or reduced to zero, as a larger 
wash volume tended to destabilize the protein, although it improved the purity. The column was eluted 
with 2 CV of elution buffer containing 0.25 M imidazole (0.1 M MES, pH 6.5/ 0.15 M NaCl/ 0.25 M 
imidazole, pH 7.5/ 10 % v/v glycerol/ 0.03 % w/v DDM). The elute was concentrated to about 0.5 ml 
using a 100 MWCO Amicon Ultra-15 centrifugal concentrator (Millipore). The concentrated elute was 
then diluted with a buffer at pH 4 (20 mM Na/citrate, pH 4.0/ 0.15 M NaCl/ either 0.03 % w/v βDDM 
or 0.023 % w/v αDDM), and concentrated back to 0.6 ml. The concentrated sample was centrifuged at 
top speed for 10 minutes to remove precipitation. The buffer exchange was designed to remove 
impurities by precipitation, especially uncleaved GFP-tagged protein. 
 
2.3.5.4. Size-exclusion chromatography by Gel Filtration: Superdex 200 
A Superdex 200 10/300 column was equilibrated with a buffer using ÄKTA 10 or 100. In total four 
types of buffer were used for gel filtration. The original buffer contained 20 mM MES (pH 6.5), 0.15 
M NaCl, and 0.03 % w/v βDDM. Later the detergent was changed to 0.023 % w/v αDDM.  For the 
purification of unstable mutants, MES (pH 6.5) was replaced with Na/citrate (pH 4.0). Protein was 
eluted at flow rate of 0.3 - 0.4 ml/min and 0.5 ml fraction size. The fractions containing NhaA was 
combined and concentrated using centrifugal concentrator 100, 000 MWCO Vivaspin 2 (Sartorius, 
Aubagne, France). The protein sample was snap-frozen in liquid nitrogen and kept at -80 ℃ until use. 
The protein concentration of the final product was assessed by BCA assay and the purity by SDS-
Page. 
 
2.3.6. Thermal Stability Assay 
Relative thermal stability of GFP-fusion protein over the pH range from 3.5 to 8.5 was measured using 
CMP based thermal stability assay (Alexandrov et al. 2008). Stock buffers ranging from pH 3.5 to 8.5 
(20 mM buffering agent/ 0.15 M NaCl/ 0.03 % w/v DDM) were prepared in advance and stored at 
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room temperature. The buffering chemicals used at each pH were the following: Na/citrate (pH 3.5, 
4.5), MES (pH 5.5, 6.5), Tris-HCl (pH 7.5, 8.5). Stock CMP dye (Sigma) was dissolved in DMSO at 4 
mg/ml, and kept at -80 ℃. Prior to use the stock was diluted 40 times in a dye dilution buffer (20 mM 
Tris-HCl, pH 7.5/ 0.15 M NaCl/ 0.03 % w/v DDM) and covered with aluminium foil to prevent 
photobleaching. A 100-µl aliquot of a buffer was pipetted into each well of MicroWell 96 well optical 
bottom plates black (Nunc), and 40 µl elute was added. Then 3 µl of diluted CMP dye was quickly 
added to each well, and the plate was incubated in plate reader pre-warmed to 40 ℃. The fluorescence 
was measured at 463 nm every 5 minutes for 1 - 2 minutes. The plate was auto-mixed for 2 seconds 
prior to measurement. After the assay, the actual pH of the buffer-diluted sample was estimated with 
pH paper. Any fluorescence data from a precipitated sample was discarded, as precipitation makes the 
measurement inaccurate.  The relative stability between different pH was determined from the slope of 
the time-resolved fluorescence emission curves. The steeper slope indicates the greater instability of a 
protein over another. 
 
Thermal stability of proteins in detergents βDDM, DM, NM, OG, and LDAO at pH 6.5 and pH 8.5 
was assessed at 40 ℃ as described (Alexandrov et al. 2008). The assay was repeated up to four times 
using different protein concentrations as sample amount permitted. The exact composition of the 
buffers are summarised in Table 2.1. An aliquot of 140 µl buffer was pipetted into each well of a 
black MicroWell 96-well optical-bottom plate, and 1 µl of purified protein sample with concentration 
between 2 - 10 mg/ml and 3 µl dye was added. Fluorescence was measured for 5 - 7 hours as 
described in the previous section. The protein concentration was experimentally adjusted to keep the 
fluorescence signal within detection limit of the plate reader. 
 
2.3.7. Half-Life Determination 
All data was processed with the program GraphPad Prism (GraphPadPrism v5 for Macintosh, 
GraphPad Software, San Diego, CA, USA). The fluorescence readings up to 140 minutes from the 
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start were selected. In order to improve the accuracy, the readings after it reached a sample’s 
maximum value and started to fluctuate were discarded. The highest fluorescence reading was 
assumed to correspond to a totally unfolded protein. The other points were plotted as fractions of this 
reading to give a curve showing the unfolding of the protein over time.  The half-life of the protein in 
each condition was calculated by fitting a one-phase decay curve to this curve.  
 
Detergent pH Buffer Salt Detergent 
DDM 6.5 20 mM MES 0.15 M NaCl 0.03 % DDM 
DM 6.5 20 mM MES 0.15 M NaCl 0.3 % DM 
NM 6.5 20 mM MES 0.15 M NaCl 0.9 % NM 
OG 6.5 20 mM MES 0.15 M NaCl 1.6 % OG 
LDAO 6.5 20 mM MES 0.15 M NaCl 0.07 % LDAO 
DDM 8.5 20 mM Tris 0.15 M NaCl 0.03 % DDM 
DM 8.5 20 mM Tris 0.15 M NaCl 0.3 % DM 
NM 8.5 20 mM Tris 0.15 M NaCl 0.9 % NM 
OG 8.5 20 mM Tris 0.15 M NaCl 1.6 % OG 
LDAO 8.5 20 mM Tris 0.15 M NaCl 0.07 % LDAO 
 
Table 2.1. Composition of the Buffer Used for Thermal Stability Assay 
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2.4. Results and Discussion 
Overall a total of 97 mutants generated through random mutagenesis were put through the screening 
funnel. As shown in Figure 2.7, this resulted in two possible thermostabilized mutants. Expression 
screening eliminated about a half of the 97 mutants and the OG solubility assay eliminated about three 
quarters of the remaining mutants. Altogether the two assays reduced the number of mutants to 14. 
FSEC and sequencing further reduced the number to 8. Finally a thermal stability assay of 8 purified 
mutant proteins identified two possible thermo-stable mutants [5]-20 and [3]-14 (circled in red in 
Table 2.2). 
 
 
Figure 2.7.  Experimental Steps and Number of Construct Selected 
The number in grey boxes is the number of constructs actually subjected to 
next round of selection. A + sign indicates the number of construct added as 
a special case 
1. Mutagenesis 
2. Expression Screening 
3. OG Solubility Screening 
4. FSEC 
5. Sequencing 
6. Purification 
7. Thermal Stability Assay 
14+1 
55 
11+1 
8 
2 
96+1 
8 
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Table 2.2. Summary of The Results of Screenings for Thermo-stable Mutants 
Summary of the mutation sites and screening results of OG tolerant, OG intolerant, and wild type NhaA.  
Legend of thermal stability assay: The samples were colour-coded to allow comparison with samples purified in the same manner. P: 
sample precipitated; *: wide 95% confidence interval; L: < lower limit (16 minutes), H: > higher than upper limit (75 minutes). 
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2.4.1. Mutagenesis & Expression Screening 
Our goal was to generate a library that contains more than 80 percent mutants with one to three amino 
acid mutations. Having a mutation rate of more than 80 percent is vital for high throughput screening.  
 
As the mutation rate of epPCR is controlled by the amount of target gene DNA used in the reaction (as 
opposed to the total amount of DNA), the first step was to identify this amount. At first a preliminary 
epPCR was set up using 2 ng, 20 ng, and 200 ng of target gene DNA per 50-µl reaction mixture. The 
first two epPCR generated colonies, which by sequencing, estimated to contain 20 and 40 percent 
mutants respectively. All three identified mutants carried two or more base pair (bp) mutations, and 
one contained a 15-bp-insertion. By extrapolation, the optimum amount was estimated to be around 1 
– 2 µg per 50-µl reaction mixture. Based on this estimation, a set of epPCR reactions was set up using 
0.8 µg, 1.4 µg, and 1.9 µg of target gene DNA, which generated libraries containing 56, 40, and 87 
colonies respectively. The percentage of mutants in the three libraries was estimated to be more than 
A C B 
 Construct ID GFP 1st Exp GFP 2ndExp Construct ID GFP 1st Exp GFP 2ndExp Construct ID GFP 1st Exp GFP 2ndExp
L10-[3]-1 522 L10-[5]-1 13,102 L10-[7]-1 4,304 3,053
L10-[3]-2 470 L10-[5]-2 428 L10-[7]-2 14,161
L10-[3]-3 10,555 L10-[5]-3 7,333 4,750 L10-[7]-3 11,352
L10-[3]-4 16,397 L10-[5]-4 10,623 L10-[7]-4 14,196
L10-[3]-5 8,778 10,342 L10-[5]-5 9,391 L10-[7]-5 372
L10-[3]-6 4,981 4,616 L10-[5]-6 13,391 L10-[7]-6 3,744 4,986
L10-[3]-7 13,465 L10-[5]-7 348 L10-[7]-7 11,750
L10-[3]-8 381 L10-[5]-8 463 L10-[7]-8 11,891
L10-[3]-9 4,836 L10-[5]-9 9,110 11,615 L10-[7]-9 13,325
L10-[3]-10 520 L10-[5]-10 1,656 2,263 L10-[7]-10 11,405
L10-[3]-11 635 L10-[5]-11 507 L10-[7]-11 16,925
L10-[3]-12 511 L10-[5]-12 13,360 L10-[7]-12 13,530
L10-[3]-13 12,321 L10-[5]-13 12,752 L10-[7]-13 16,086
L10-[3]-14 11,353 L10-[5]-14 13,554 L10-[7]-14 15,989
L10-[3]-15 10,383 L10-[5]-15 12,080 L10-[7]-15 12,853
L10-[3]-16 4,653 L10-[5]-16 404 L10-[7]-16 15,173
L10-[3]-17 13,770 L10-[5]-17 12,102 L10-[7]-17 13,046
L10-[3]-18 405 L10-[5]-18 4,403 3,340 L10-[7]-18 458
L10-[3]-19 13,848 L10-[5]-19 399 L10-[7]-19 16,085
L10-[3]-20 8,093 L10-[5]-20 13,165 L10-[7]-20 456
L10-[3]-21 824 L10-[5]-21 429 L10-[7]-21 11,529
L10-[3]-22 5,457 L10-[5]-22 14,610 L10-[7]-22 3,940 4,229
WT2 3,286
WT1 3,633
Figure 2.8. Small-scale Expression of Mutants Generated by epPCR  
Template DNA volumes were A 3 µl B 5 µl C 7 µl. Mutants with no expression 
are highlighted with grey. Rows highlighted with pale blue are wild type.  
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80 percent, as most of the constructs showed non-wild-type expression levels (Figure 2.8). 
Sequencing of 6 constructs from condition B (1.4 µg gene) gave the estimate of around 83 percent 
mutants, which contained one to four amino acid mutations. As the expression profile of constructs 
generated by condition A was similar to the ones generated by condition B, we assumed the two 
conditions were equivalent. Thus total of 96 constructs generated from reactions A and B were 
selected for further screening. In addition, in the preliminary epPCR run it was noted that one of the 
constructs contained the mutation H256Q that is situated in the suspected pH sensor region (Padan et 
al. 2009).  Since this is of interest for the function of NhaA it was decided to also carry out the 
screening with this mutant.  
 
The results of the expression screening are shown in Figure 2.9.A. Expression trials were carried out 
using BL21(DE3)pLysS cells. The expression levels were monitored using the fluorescence signal 
generated by the C-terminal GFP tag. All the constructs that expressed less than 1 mg GFP/L (GFP 
count ~3, 000) were eliminated. This expression level set the lower limit for obtaining reproducible 
 
Figure 2.9. Summary of The Results of Expression and Octyl Glucoside Solubilization 
Efficiency Assay 
A. Results of Expression Screening Assay 
B. Results of Octyl Glucoside Solubilization Efficiency Assay of NhaA Constructs 
A B 
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results in the subsequent assays. The assay eliminated 43, or about a half of the mutants reducing the 
number of constructs to 54. 
 
2.4.2. OG Solubility Efficiency Screening 
2.4.2.1. Result and Rate of Stabilizing Mutations 
As shown in Figure 2.9. B, 14 constructs passed the cut-off mark of 50 percent solubility efficiency in 
4 % w/v OG. The screening eliminated about three-quarter of the 54 constructs. Mutants with high 
solubility in 4 % OG (OGH) also showed high solubility in 2 % OG, and mutants with low solubility in 
4 % OG (OGL) also showed low solubility in 2 %. However, the converse was not true. Some mutants 
showed lower solubility in 4 % OG than in 2 % OG for some unknown reasons. This suggests that 2 % 
OG, as is typically used to extract integral membrane protein from membrane fraction, is not always a 
reliable fraction for screening. Screening the solubility with both 2 % and 4 % w/v OG allowed us to 
make a more reliable assessment.  
 
As a control of how informative this assay was, four OGL constructs (constructs that did not pass the 
criteria of 50 percent solubility in 4 % w/v OG) with varying degrees of solubility in OG were selected 
as negative controls for the thermal stability assay. The negative controls include the mutant H256Q, a 
mutant with a point mutation at the suspected pH sensor region (Padan et al. 2009). In addition one 
construct ([5]-9) was included in the thermal stability assay, as it once showed more than 50 percent 
solubility in 2 % w/v OG, the criterion used by other researchers in our group. 
 
2.4.3. FSEC 
Using FSEC, 3 constructs were eliminated out of the 14 OGH mutants that passed the OG solubility 
screening criteria. The assay identifies proteins that are aggregated or unfolded using gel filtration 
chromatography of the solubilized membrane sample. In general, the FSEC profile of membrane 
samples solubilized in particular detergents closely resembles the profile of the purified protein in the 
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same detergent. The presence of peaks corresponding to protein aggregation, polydispersion, high 
GFP (protein unfolding), or destabilization in harsh detergent LDAO, was used as elimination criteria.  
 
The FSEC profiles of eliminated constructs are shown in Figure 2.10. No constructs exhibited 
aggregation peaks nor multiple-elution peaks from the samples of DDM solubilized membranes. This 
suggests they could be purified in DDM without aggregation, giving a monodispersed sample. 
However, the DDM solubilized samples of constructs, [3]-4 and [3]-13 exhibited a relatively high free 
GFP peak (Figure 2.10. A). This implies they are more prone to unfolding, and as a consequence, are 
proteolyzed. Construct [5]-33 showed peak broadening in LDAO. As LDAO is a harsh detergent, this 
indicates that the construct is not stabilized, contrary to its high OG solubility may suggest. Thus three 
constructs, [3]-4, [3]-13, and [5]-33, were eliminated as unstable mutants.  
 
All 14 constructs that passed OG solubility assay and one construct that exhibited high solubility 
efficiency only in 2 % OG (construct [5]-9) was sequenced. Sequencing showed that out of the 11 
constructs that passed the FSEC criteria, two were identical, two contained silent mutations, and one 
A B 
Figure 2.10.   FSEC Profile of Eliminated Mutants 
 
 45 
was identical to an OGL construct. Thus the number of selected mutants was reduced to 7. With the 
inclusion of construct [5]-9, a total of 8 constructs were passed to the next stage. The 8 candidate 
mutants and 4 OGL (negative control) mutants were purified and subjected to the thermal stability 
assay. 
 
2.4.4. Thermal Stability Assay 
2.4.4.1. Protein Sample Preparation 
As the project progressed, the method of purification was modified slightly. The purification method 
should be equivalent for all constructs in a normal screening method. However, the OGL mutants were 
expected to be unstable, and it was possible that different mutants could have different pH profiles, as 
the protein is sensitive to pH. It was felt that the detergent-based screening should be evaluated by 
thermal stability assay, and that stability differences due to different purification methods could be 
accommodated within the error margins of the assay without sacrificing the aim of identifying 
significantly thermostabilized mutants. In addition, detergent was changed to αDDM, the isomer 
reported to improve the diffraction quality (Screpanti et al. 2006), as it was decided to utilize the same 
sample for crystallisation trials. At first, the host cell line was changed to BL21(DE3)C43, as 
preliminary showed the yield of 
BL21(DE3)pLysS cells were low. However, 
expression of a few mutants failed 
repeatedly for unknown reasons. In such 
cases, membrane samples prepared from 
BL21(DE3)pLysS cells were utilized for 
protein purification. As a result, mutants 
were purified using three different methods 
(Figure 2.11). For comparison, wild type 
protein was also purified likewise. 
Beta DDM 
Orange 
Green 
Yellow 
Alpha DDM 
C43 pLysS 
Figure 2.11. Difference Between 
Purification Methods  
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2.4.4.2. Results of the Assay 
The measured half-lives of mutants are summarized in the Table 2.3. The mutants and wild type 
samples are colour coded to allow comparison with a wild type purified in the same manner. As 
shown in Table 2.3, the stability was measured at pH6.5 where the protein is inactive and pH 8.5 
where it is active. The assay was performed up to three times. As shown in lines 13-17 of Table 2.3, 
wild type NhaA rapidly unfolds in OG and LDAO at pH 6.5. It is marginally stable in DDM at pH 8.5 
and rapidly unfolds in harsher detergents. As shown in lines 2, 5, 8, two mutants, constructs [5]-20 
and [3]-14, appeared to be more stable than wild type across various detergents at the active pH of 8.5.  
 
2.4.4.3. Reproducibility and Accuracy of the Assay 
The reproducibility of the assay was high if the batch and sample concentration used to measure the 
assay were the same (data not shown). As the half-life of up to five wild-type samples were measured 
at each run, their half-life values allow us to estimate the effects of different batch, purification 
methods, and host cells might have on thermal stability of protein (lines 13-17). The first three wild 
type samples show that the variations of half-life among different batches is less than 10 minutes in 
DM, NM and LDAO at pH 6.5 and DDM at pH 8.5 (lines 13-15). Similarly the variations in half-life 
of samples purified using two different methods is around 10 minutes in DM and NM at pH 6.5 and 
DDM at pH 8.5 (lines 13-16). The stability of samples expressed in different host cells is also similar 
in NM at pH 6.5 and DDM at pH 8.5 (lines 16, 17). These comparisons suggest that effects of 
differences in batch, purification methods, and host cells are less pronounced at mildly destabilizing 
conditions.  
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The limited range of accuracy and reproducibility may be due to the way half-life is measured and 
calculated. The thermal stability assay measures protein unfolding indirectly by monitoring the 
fluorescence emitted by the CPM dye covalently attached to cystein residues over a period of time at a 
constant temperature of 40 °C.  As the protein unfolds, more cysteines become exposed and hence are 
able to interact with the dye. The values are converted to the fraction of protein remaining folded, and 
a one-phase decay curve is fitted to the unfolding curve. The unfolding curves of constructs in various 
detergents show that some curves do not fit exactly to the one phase decay curve (Figure 2.12). At 
Table 2.3. Half-Life of Mutants and Wild Type NhaA 
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milder conditions, such as DDM and DM at pH 6.5, the unfolding curve is sigmoid. At harsh 
conditions, best demonstrated in OG, the curves exhibit irregularities, such as no plateau, sudden 
drops, and lower plateau level than milder conditions (eg. DDM). The sigmoid curve leads to 
overestimation, and irregular curves leads to inaccurate measurements.  Nevertheless it was felt that a 
simple one-phase decay curve is suitable for the analysis, as the assay is only to give a crude relative 
estimate of the stability.  
 
2.5. Assessment of Screening Methods and the Mutational Approach 
2.5.1. Efficacy and Efficiency of Screening Methods 
The efficacy of this random mutagenesis approach to generate mutants and then to investigate their 
stability using a screening funnel can be seen from the results. As shown in Figure 2.13, random 
mutagenesis generated mutations throughout the molecule. The mutants [5]-20 and [3]-14, identified 
as thermostable from the thermal stability assay, are A89T/F136L double mutant and 
I63K/V231A/L296M triple mutant respectively. Although we examined the interactions of these sites 
to their neighbouring residues in the published NhaA structure thought to be in an inactive 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.12. Unfolding Curve of A. Stable and B. Unstable Mutants 
A B 
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conformation, we were unable to explain how stabilization might have occurred (Figure 2.13 and 
Table 2.4). This demonstrates the advantage of random mutagenesis over a bioinformatic approach.  
 
Figure 2.13. NhaA Mutation Sites 
A. 2D diagram 
All confirmed mutation sites were circled in purple. Reported functional mutants are indicated with 
coloured circle except green. It is apparent that mutagenesis generated mutations throughout the 
molecule. Red is residues inactivated the protein upon mutation, blue is residues affected pH-
dependant response, orange is residues affected Km. Green is residues involved in dimerization. 
 
B. 3D image of NhaA Mutation Sites 
All conformed mutation sites were indicated as orange sticks, and residues implicated in 
dimerisation as forest green sticks.  
A 
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Sample ID  Mut1   Mut2   Mut3   Mut4   
[3]-14 I63K NSC V231A NSC L296M NSC     
[3]-16 R203C NSC G338C SC & FC?         
[3]-52 V231I NSC             
[3]-55 D40E NSC             
[3]-7/54 G185S NSC             
[5]-1 L53F NSC I191T NSC P289S SC?     
[5]-15 M84I NSC             
[5]-20 A89T NSC F136L NSC         
[5]-28/37 Y38H SC&FC             
[5]-3 L165H SC&FC? A373G NSC         
[5]-33 L156V NSC             
[5]-34 R203H NSC             
[5]-5 N64S NSC L173F NSC S183F NSC R313H NSC 
[5]-6/14 R313H NSC             
[5]-9 A109T SC? Q277H NSC         
256H2Q H256Q NSC             
 
  
 
Table 2.4. List of NhaA Mutation Sites 
 
SC: possible structural consequences, NSC: no structural consequences, FC: possible functional 
consequences, NFC: no functional consequences  
Disrupts movement of helix IV 
Alter loop structure 
2 H-bond with C=O group on helix IX lost? 
Alter charge distribution at substrate binding site? 
H-bond with C=O of 105M (III) & 127A (helix IV) lost? Hindering 
helix IV movement? 
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The results of the screening show how an indication of protein stability can be obtained under various 
destabilizing factors, such as solubility in OG, analytical chromatography in LDAO, and thermal 
stability in various detergents and pH. The results also show detergent solubilized membrane, instead 
of purified protein, could be utilized to speed up the screening. The comparison of thermal stability 
profile between OGH and OGL mutants suggests there to be a correlation between OG solubility and 
thermal stability. OGL mutants have generally shorter half-life than the OGH mutants or wild type. The 
stability assay included four OGL mutants, [5]-28/37, [3]-52, 256H2Q, and [3]-55. Mutants [5]-28/37 
and [3]-55 have shorter half-life across the conditions measured.  
 
Out of the 14 candidate mutants identified by OG solubility assay, two were thermostable, two were 
wild type, and six were thermo-unstable. This puts the rate of false positive for the OG solubility assay 
alone to around 43 percent. The figure is rather high. The measurement in two OG concentrations and 
repeated experiments improved the reliability of the OG solubility assay. There are six constructs that 
showed higher solubility in 2 % OG than in 4 % OG at least once, and fifteen constructs that passed 
Postulated substrate 
Binding Sites 
A B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.14. Mutation Sites of Thermostable Mutants [3]-14 and [5]-20 
 
A. The Mutation Sites in NhaA Dimer 
B. Zoomed Mutation Sites: Cytosolic Face 
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the cut off mark in one of the measurements. The numbers suggest these two safety measures halved 
the rate of false positive. Assessing detergent stability over several destabilizing detergents, such as 
NG and DG, rather than depending on only one detergent might further improve the reliability, as 
profiling could enhance detection of false positive. 
 
The efficiency of the screening owes much to the use of assays targeted against the detergent 
solubilized membrane containing the protein of interest rather than the purified protein. The 
combination of expression screening, OG solubility assay, and FSEC eliminated close to 90 percent of 
mutants. Random mutagenesis also contributed to the efficiency as it generated mutations throughout 
the molecule in short time. The use of detergent solubilized membrane and random mutagenesis 
enabled us to generate and screen thermostable mutants in a relatively short time.  
 
2.5.2. Rate of Stabilizing Mutation 
The rate of stabilising mutations in NhaA is lower than the ten percent estimate postulated by Bowie 
(Bowie 2001). It is more in line with the five percent figure of β1AR, a GPCR (Serrano-Vega et al. 
2008). The ten percent estimate was based on mutagenesis of four membrane proteins, the 
transmembrane segment of the M13 coat protein, DGK, KcsA K+ channel, and helices B and D of 
bacteriorhodopsin. They are from different families and contain varying numbers of transmembrane 
helices. This suggests further mutation studies of other proteins from different families are necessary 
to give more accurate estimate of the rate of stabilizing mutations in membrane protein. Nevertheless, 
this project demonstrated the feasibility and practicality of mutational thermostabilization.  
 
2.5.3. The limitation of Thermostabilization 
Increasing the thermal stability of a membrane protein can lengthen the lifetime of the protein under 
conditions suitable for crystallization. This, in turn, could enhance the possibility of obtaining crystals 
under these conditions. However, thermostabilized protein may still not crystallize. 
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Thermostabilization of DGK was one such case (Lorch et al. 2005). This reminds us that the thermal 
stability is only one of the many factors influencing membrane protein crystallization. For instance, 
conformational homogeneity is known to affect crystallization, as demonstrated by crystallization of 
several GPCRs (Jaakola et al. 2008; Rosenbaum et al. 2007; Warne et al. 2008). The 
thermostabilization of β1AR produced several thermostable mutants, one of which was found to favour 
one conformation. They modified the thermostabilization screening later so that the screening was 
performed on particular conformation (Magnani et al. 2008). Unfortunately the method is not 
universally applicable as the screening used labelled agonist/antagonist.  
 
2.6. Possible Improvements to the Screening 
As in any protocol, there is always room for improvement, and this screening method is no exception. 
The efficiency of the screening could be further improved by incorporation of another thermal 
screening at the beginning.  
 
Among the four screenings, the OG solubility assay was the bottleneck.  The preparation of membrane 
samples and the need for repeated measurements were exhaustive. The problem was that the number 
of constructs was only halved at this stage. The assay required preparation of membrane samples and 
measurement of solubility in different detergents of 55 constructs and wild type. Halving of the 
number by introducing one more layer of screening prior to the assay would make this assay 
manageable. 
 
Among the numerous screening methods published, those based on whole cells based assays are 
probably one of the fastest. Sarkar et al screened GPCR mutants with enhanced expression, stability 
and binding selectivity in vivo using cytometry using a fluorescent ligand (Sarkar et al. 2008). They 
further streamlined screening by using E. coli DH5α cells and a pBR322 based expression vector for 
transformation and expression, thereby eliminating the need for the transformation of the colonies into 
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another cell line prior to expression. A thermal stability assay of DGK measured the enzymatic 
activity of OG solubilized whole cell samples (Zhou & Bowie 2000). However, these methods cannot 
be applied as a general methodology since these require labelled ligands to be available.   
 
Fluorescence resonance energy transfer (FRET) has been used to measure the distance of a fluorescent 
protein pair. The assay is based on energy transfer between two fluorescent proteins, and it is very 
sensitive to distance (Piston & Kremers 2007). Philipps et al fused fluorescent proteins (blue and 
green) at N- and C-termini of two antibody domains to measure stability and folding of the domains 
(Philipps et al. 2003). It would be interesting to explore if the assay could be adapted to determine 
whether whole protein molecules are folded. FRET works in the distance of 20 to 60 Å (Villalobos et 
al. 2007), the distance that may restrict the use to a limited number of proteins. 
 
2.7. Conclusion and Future Direction 
The high efficacy and efficiency of this high throughput mutational thermostabilization clearly 
demonstrate the potential of this approach. The advantage of this method is its universal applicability. 
The mutagenesis and screening could be performed on any protein with no prior biochemical 
characterization. The screening requires neither labelled ligand nor special instrumentation save for 
the plate reader.  
 
The project’s main aim was to establish the methodology for high throughput thermostabilization 
screening. The result clearly showed the approach is valid. Since the thermostabilization was modest, 
the identified mutants need further stabilization. The mutation sites could be combined to optimize the 
effect. The pool of thermostabilizing mutations could be enriched through new round of mutagenesis 
and screening using either wild type gene or identified mutant gene. For instance, modest thermal 
stability of β1AR was enhanced by combination and substitution of identified mutations (Serrano-
Vega et al. 2008). 
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CRYSTALLIZATION OF 
ESCHERICHIA COLI SODIUM-PROTON 
ANTIPORTER 
NHAA
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3.1. Introduction 
As described in the previous chapter, NhaA is a bacterial Na+/H+ antiporter that regulates the 
concentration of cytosolic sodium ions and protons in the cell (Padan 2001). The crystal structure of 
NhaA at pH 4 was determined at 3.45 Å resolution in 2005 (Hunte et al. 2005). Although studies have 
suggested that NhaA exists as a dimer in the lipid bilayer as often found in 2D crystals (Hilger et al. 
2005; Williams et al. 1999), the arrangement of the molecules in the crystal structure was not 
consistent with a physiological dimer.  
 
 
NhaA is fully functional as a monomer (Rimon et al. 2007), and two slightly different transport 
mechanisms have been proposed (Arkin et al. 2007; Padan et al. 2009) based on biochemical studies, 
the crystal structure, and model obtained by cryo-EM and electron spin resonance (ESR) (Figure 3.1) 
(Appel et al. 2009; Hilger et al. 2005; Hunte et al. 2005). The main differences between the models 
 Figure 3.1. Proposed 
Transport Mechanisms of a 
Na+/H+ Transporter, NhaA 
 
A. A model proposed by 
Arkin et al (Arkin et al. 
2007) 
 
B. And by Padan et al 
(Padan et al. 2009) 
 
The main differences 
between the models are the 
residues involved in 
substrate binding and 
binding of which ion 
triggers conformational 
change. 
A 
B 
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are the residues involved in substrate binding, and the binding of which ion triggers the 
conformational changes necessary for the ion transport. Atkins’ model identifies D163 and D164 on 
the helix V as substrate binding, whereas Padan’s model adds T132 and D133 on the helix IV to the 
substrate-binding site. Atkins’ model proposes the protonation and deprotonation of D163 drives the 
transport. Padan’s model suggests Na+/Li+ binding and protonation of D163 and D164 run the 
transport cycle (Arkin et al. 2007; Padan et al. 2009). Cryo-EM data seems to support Padan’s model, 
as pH shift alone did not cause any significant helix movement (Appel et al. 2009). 
 
As mentioned, recently the physiological dimer structure was obtained by both cryo-EM at a 
resolution of about 7 Å and pulsed electron paramagnetic resonance (PDB accession code: 3FI1) 
(Appel et al. 2009; Hilger et al. 2007). The model suggested dimerization is mediated by the residues 
 
Figure 3.2. The Dimer Model of NhaA (Appel et al. 2009) 
The residues proposed to mediate dimerisation are shown as green sticks. 
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on the β-sheet and the helices VII and IX. The involvement of the β-sheet was later conformed by the 
study of deletion mutants (Herz et al. 2009). As Figure 3.2 shows, a 2-fold symmetry axis runs in the 
middle of the dimer interface perpendicular to the membrane normal. Helix IV, observed to be the 
most mobile helix upon substrate binding by cryo-EM (Appel et al. 2009), is located at the periphery 
of the complex, with the corresponding helices from the two subunits of the dimer leaning in opposite 
directions. It has been observed that the growth of dimerization deficient mutants was severely 
restricted under the conditions that call for maximum transport activity. Hilger et al proposed that ion 
transport involves a cooperative and asymmetric motion of the monomer moieties in the dimer based 
on a mutant complementation study (Hilger et al. 2007). Appel et al on the contrary excluded the 
allosteric effect of dimer on the transport on the basis that cryo-EM showed all functional elements 
were contained within one monomer (Appel et al. 2009). Obtaining the crystal structure of the 
physiological dimer would greatly enhance our understanding on the nature of interactions at dimer 
interface.  
 
3.2. Aim 
Since only one crystal structure of NhaA has been reported, we submitted the mutant transporters 
identified as having either greater or less thermostability than wild type as described in the previous 
chapter with the aim of obtaining a higher resolution of the protein or a structure of the protein in an 
alternative conformation.  
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3.3. Materials and Methods 
All detergents were purchased from Anatrace (Maumee, OH, USA) and chemical reagents were from 
Sigma-Aldrich unless specified otherwise. Crystallization-screening kits were from Molecular 
Dimensions. Protein samples were the same as those prepared for the thermostabilization experiments 
of NhaA discussed in the previous chapter.  
 
 Prior to the start of the project, Dr. David Drew of Imperial College London had performed the initial 
optimisation of the crystallization condition. The condition (MG-H4*) contains 0.1M Na/citrate (pH 
3.5), 0.2 M Li2SO4, and 28 % w/v PEG 400 (Fluka), and 1 % n-Heptyl-β-D-thioglucoside (HTG). 
HTG was added to either reservoir or protein samples. This condition used protein sample purified in 
βDDM at pH 6.5. 
 
3.3.1. Crystallization Condition Screening 
Crystallization screening was set up for all constructs that were purified for the thermostability assay 
regardless of their stability. The proteins were screened using the commercially available sparse 
matrix screening kits MemSys, MemStart, and MemGold using a Cartesian robot (Hamilton). The 96 
wells of the sitting drop plates contained 85 µl reservoir solution. 100 nl of reservoir solution was 
mixed with 100 nl of sample. As described in the previous chapter, the majority of the samples were 
purified in αDDM. The plates were incubated at 20 ℃, and examined for crystals at regular intervals 
for a week, and then on a monthly basis. 
 
3.3.2. Crystallization Condition Optimisation and Crystal Optimisation 
In addition, as sample amount permitted, most of the constructs were subjected to a narrower screen 
around the condition that was observed to produce the best diffracting crystals for the wild type 
construct (“MG-H4*”). Crystals were grown with the hanging drop vapour diffusion method at 20 ℃. 
V 
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1 ml reservoir solution was used in each well of the 
24 well plates. The drop was prepared by mixing 1 
μl of the reservoir solution with 1µl of protein 
sample (10 mg/ml). 
 
Various additives, such as detergents and HTG, 
were examined to optimize the condition MG-H4*. 
The effect of shorter chain non-ionic detergents 
(UM, DM, NM, OG) or zwitterionic detergent 
LDAO was examined.  A buffer containing various 
detergents at about 1.4 times its CMC was added to a protein sample in a volume ratio of 3:1. The 
diluted sample was either used immediately to set up a crystallization experiment, or incubated 
overnight on ice before the set up.  The reservoir condition was as described for MG-H4* with PEG 
concentration variation between 26 to 32 % v/v. The detergents and their final concentrations were 
summarized in the Table 3.1. For HTG concentration optimisation, a crystallization experiment was 
set up between 0 to 2 % w/v HTG at 0.5 % increments with 26 - 32 % v/v PEG concentrations using 
the condition MG-H4*. Crystals were either harvested and snap frozen in liquid nitrogen, or used for 
other optimization experiments described in the following sections. 
 
Dehydration experiments were performed by transferring a cover slide containing the crystallization 
drop to a well containing the MG-H4* reservoir condition with PEG concentration increased to 35 % 
v/v. The drops were equilibrated at least overnight. The cover slides were then successively moved to 
reservoir conditions with 5 % higher PEG concentration than the previous well until the PEG 
concentration reached a maximum of 55 %. Crystals were incubated at one PEG concentration for 
various lengths of times, and crystals were harvested at various points of dehydration process to 
determine optimum conditions. 
Detergent Concentration 
w/v 
CMC 
UM 0.041 % 0.029 % 
DM 0.12 % 0.087 % 
NM 0.39 % 0.28 % 
NG 0.28 % 0.2 % 
OG 0.14 % 0.53 % 
LDAO 0.032 % 0.023 % 
Table 3.1. Concentration of the 
Detergent Used for Detergent Additive 
Experiment 
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3.4. Results and Discussion 
Mutations, especially on the protein surface, can affect crystallization by altering the crystal packing 
(Granata et al. 2005; Wine et al. 2009). For this reason all the constructs that were purified for the 
thermostability screening were subjected to crystallization trials. In essence, crystallization profile, 
crystal morphology, resolution, mosaicity of all mutants were similar to wild type. The resolution was 
strongly correlated with sample purity as reported by Hunte and colleagues (Screpanti et al. 2006).  
 
As mentioned in the preceding chapter, mutants were purified in either α or β isomers of DDM. The 
change was made to improve crystallization as Hunte and colleagues reported that better diffraction 
was obtained from samples purified in the α isomer (Screpanti et al. 2006). Although our construct 
differed from theirs (no His tag), crystals grown from protein that was purified in αDDM were much 
better in terms of crystal morphology and diffraction quality as reported (Screpanti et al. 2006). The 
βDDM purified samples produced cuvettes, rhombic prisms, or plates at the condition MG-H4* 
(Figure 3.3. A), which diffracted around 10 – 40 Å (Figure 3.4. A). The detergent exchange to 
αDDM by repeated dilution of the protein with buffer containing αDDM followed by concentration 
produced a mixture of cuvettes and rhombic crystals (Figure 3.3. B). The extremely fragile rhombic 
crystals showed severely poor and mosaic diffraction (Figure 3.4. B). When the exchange was 
performed during size-exclusion chromatography, crystals were either skewed hexagonal or rhombic 
and the diffraction was improved to about 4 Å (Figure 3.3. C – F, Figure 3.4. C). 
 
The best diffracting crystals were obtained from the condition MG-H4* at pH 3.5. The crystals 
diffracted to a resolution of around 4 Å, a resolution slightly lower than that reported by Hunte et al 
(Hunte et al. 2005). In contrast the resolution of any crystals that grew in higher pH conditions where 
the protein should be active was between 6 and 8 Å.  
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Figure 3.3. The Effect of Detergent on Crystal Morphology 
A. Crystals obtained from samples purified in βDDM 
B. From samples which detergent exchanged from β to αDDM 
C – F. From samples purified in αDDM 
A B 
D E F 
C 
 
A B C 
Figure 3.4. The Effect of Detergent on Diffraction Quality 
A. Diffraction Pattern of Crystal Grown from Samples Purified in βDDM 
B. From Samples Detergent Exchanged from β to αDDM 
C. From Samples Purified in αDDM 
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3.4.1. NhaA Dimer Complex Crystal 
The best diffracting crystals had a skewed hexagonal morphology (Figure 3.3. C). Initially these 
crystals were obtained from a mutant protein that was, in fact, less thermostable than the wild type 
protein. However subsequently the same crystals were obtained with another less thermostable mutant 
and the wild type protein. The thermostable mutants did not produce crystals at the MG-H4*, probably 
due to either slightly lower protein concentration or poorer purity. During the initial screening, 
anisotropic diffraction was observed with diffraction to 4 Å in one direction, and 6 Å in the others. 
Although the morphology of these crystals varied from skewed hexagonal to rhombic (Figure 3.3. C - 
F), data analysis showed the space group and cell dimensions to be the same. In order to improve the 
resolution and reduce the anisotropy, optimization of both crystallization and crystal harvesting 
conditions were attempted on a limited scale.  
 
3.4.2. Crystallization Condition and Crystal Optimization 
The optimization of crystallization condition produced no tangible improvement in resolution or 
anisotropy. The addition of various detergents had no impact on diffraction. Addition of LDAO had 
either no impact on crystallization 
and diffraction quality, or 
precipitated the protein. When 
proteins were incubated overnight 
after the addition of OG, 
crystallization drops produced 
ragged rhombic crystals. Addition 
of HTG was essential, but crystal 
quality was similar between HTG 
concentrations of 1 %, 1.5 %, and 
2 %. 
<- b axis 
Figure 3.5. Crystal Packing of NhaA 
Dimer Complex  
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Due to the variation in diffraction between different crystals it is difficult to assess the success of the 
dehydration method. However, the best diffracting crystals were dehydrated and on average had a 
shorter unit cell dimension in the b direction (Figure 3.5). Neither the optimum PEG concentration, 
nor the optimum time for length of incubation length was identified for the dehydration of NhaA 
dimer crystals. Crystals dehydrated at PEG 400 concentration of 45 %, 50 % or 55 % diffracted 
similarly. Similarly crystals incubated for a few days and more than 10 days diffracted to similar 
resolution. 
 
3.4.3. X ray Diffraction Data Collection and Analysis of NhaA Dimer 
Four diffraction datasets were collected from single crystals at beamlines I02 and I24 of Diamond 
Light Source in Didcot, Oxfordshire, UK. The crystals belonged to the space group P21. As the 
crystals were much larger than the X-ray beam, data were collected in a series of wedges along the 
length of the crystal. Data processing and scaling were performed with the programs HLK2000 
(Otwinowski & Minor 1997), Phenix (Adams et al. 2002), and CCP4 suite (Collaborative 
Computational Project 1994). The crystallographic data is summarised in Table 3.2.  
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Dataset [3]-55_A WT_A [3]-55_B [3]-55_C 
BL I02 I02 I02 I24 
Resolution (Å)* 4.2 4.2 3.8 3.8 
Space Group P21 P21 P21 P21 
a 115.6 115.9 115.9 115.8 
b 103.7 103.5 101.0 100.6 
c 141.5 141.8 141.1 141.6 
α 90 90 90 90 
β 96 96.6 96.6 97 
Unit Cell 
Parameters 
γ  90 90 90 90 
Solvent Fraction (%) 75.9 75.7 75.2 75.1 
Total Reflections 109, 624 107, 000 101, 735 134, 749 
Unique Reflections 27, 407 26, 751 35, 485 40, 331 
Resolution Range (Å) 29.6 - 3.9 29.5 – 4.0 30.00 - 3.60 30.0 - 3.50 
Completeness (%) 96.4 95.5 96.0 98.7 
Rmerge (%) 8.8 8.6 8.1 10.2 
Multiplicity 1.6 3.7 3.9 3.3 
Average I/sigma (I) 6.98 7.74 6.82 8.49 
Resolution 
Range 
4.00 - 4.14 4.00 - 4.14 3.60 - 3.73 3.50 – 3.62 I/sigma (I) at 
Highest 
Resolution I/sigma (I) 0.79 1.04 0.94 0.96 
Sample [3]-55 [3]-17 [3]-55 [3]-55 
Reservoir 
Condition 
0.1 M Na/cit 
(pH 3.5), 0.2 
M Li2SO4, 26 
% PEG 400 
0.1 M Na/cit 
(pH 3.5), 0.2 
M Li2SO4, 26 
% PEG 400 
0.1 M Na/cit 
(pH 3.5), 0.2 
M Li2SO4, 26 
% PEG 400 
0.1 M Na/cit 
(pH 3.5), 0.2 
M Li2SO4, 28 
% PEG 400 
Additive 1 % HTG 1.5 % HTG 1 % HTG, 
0.74 % OG 
1 % HTG, 
0.28 % NG 
Crystallization 
Dehydration No No 35 % x 1 day, 
40 % x 9 day 
55 % PEG 
dehydration 
 
Table 3.2. Crystallographic Statistics 
 
* The cut off at I/sigma value of 2 
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C 
  
A 
B 
Figure 3.6. Calculated Electron Density Omit Map* and 
Dimer Models 
 
A. Monomer 
B. Close-up of the β-sheet 
Colour codes: peptide chains in light blue and purple are 
of cryo-EM model, and grey-green and mustard yellow 
are of the preliminary structure model. The 2FO-FC map 
is in grey mesh, and FO-FC difference map is in green 
and red mesh.  
 
*The maps were calculated using coordinates of a β-sheet deleted 
monomer. 
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3.4.4. Preliminary Structure Determination 
The reported NhaA crystal structure (1ZCD) has 2 monomers in the asymmetric unit in non-
physiological orientation. The initial electron density map was calculated by molecular replacement 
using coordinates of one monomer as a search model. 4 molecules were found to be present in the 
asymmetric unit, which were arranged as 2 dimers. Surprisingly, rather than the non-physiological 
arrangement reported in the 3D crystal structure, relative positioning of monomers in dimer complex 
was in close agreement to the reported dimer structure by cryo-EM (3FI1).   
 
The best datasets were [3]-55_B and C, obtained from dehydrated crystals. With only rigid body 
refinement, the R-factor of the dataset [3]-55_B was 39.1 %. Overall the electron density clearly 
showed the positions of the helices in the structure. The β-sheet at the dimer interface was less well 
defined, but its position could be clearly seen in the map.  
 
To eliminate model bias, the residues associated with the β-sheet were deleted from the model 
(residues 33-58), and a map was recalculated. The omission improved the R-factor to 36.5 %. Figure 
3.6. A shows the calculated omit map and original solution of molecular replacement with the reported 
cryo-EM model superimposed. It is clear that the position of the β-sheet is slightly different to that 
modelled based on the cryo-EM map (Figure 3.6. B). Appel and colleagues rotated the β-sheet in 
order to fit the dimer into the cryo-EM map density (Appel et al. 2009); however, precise position of 
the β-sheet is difficult to determine at this resolution. 
 
3.5. Conclusion 
The crystallization of wild type and mutant NhaA led to preliminary structure determination of novel 
dimer complex at a resolution of 3.8 Å. Since refinement is difficult at this resolution this has not yet 
been carried out. Further work by other researchers is underway to refine the structure.  
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ENHANCED CRYSTALLIZATION 
BY CONSTRUCT ENGINEERING: 
INSECT P450S 
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4.1. Introduction 
Cytochrome P450s are peripheral (monotopic) membrane proteins. They are anchored to the protein 
by a single membrane spanning α-helix. Since the region of interest is in the cytosolic part the helix 
can be removed to aid purification and crystallization, as the deletion could enable detergent-free 
purification (Guengerich et al. 1997). 
 
4.1.1. Model Proteins: Insect P450s involved in Ecdysone Biosynthesis 
In this project, we were interested in solving the structures of four insect P450 proteins from 
Drosophila melanogaster (fruit fry) and their homologues in Bombyx mori (silk worm). All eight 
proteins are thought to be involved in biosynthesis of moulting steroid ecdysone.  
 
4.1.1.1. Ecdysone: Precursor to a Moulting Steroid 20-hydroxyecdysone 
The development of many insects is punctuated by moulting, and a failure to do so leads to physical 
abnormalities, developmental arrest, and eventual death (Rewitz 2009). The serge of ecdysone and its 
derivative 20-hydroxyecdysone in body fluid initiates the moulting process (Rewitz et al. 2006a).  The 
enzymes involved in ecdysone synthesis were first identified from studies of lethal mutations in D. 
melanogaster and were named Halloween genes (Gilbert 2004; Rewitz et al. 2007). Homologues in B. 
mori have also been identified later.  
 
4.1.1.2. Enzymes Involved in Ecdysone Biosynthesis 
Following the initial work the ecdysone biosynthetic pathway has been painstakingly elucidated 
through numerous studies. As shown in Figure 4.1 ecdysone is synthesized from either dietary 
cholesterol or plant sterol (Brown et al. 2009). Although the last steps of the pathway are well 
characterized, the first part of the conversions is not well understood. The conversions take place in 
the cytosol, endoplasmic reticulum, and mitochondria. Three of the four target proteins, phantom 
(phm), disembodied (dib), shadow (sad), are involved in the terminal oxidation of the synthetic 
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intermediates. Sad catalyzes the last step of the synthesis of ecdysone. Ecdysone is then secreted by 
ecdysial tissue, and converted to 20-hydroxyecdysone at peripheral tissues by shade (CYP314A1) in 
mitochondria. The exact enzymatic role of spook (spo) is still unclear, although biochemical studies of 
the protein suggested it may be involved in the so called “black box reaction”, the non-elucidated part 
of the pathway (Brown et al. 2009; Namiki et al. 2005; Rewitz et al. 2006b). The exact location of the 
two P450s dib and sad within mitochondria is also still unclear (FlyBase) (Tweedie et al. 2009). 
 
Phm, dib, sad, and perhaps spo, are all monooxygenases. They oxidize carbon using an activated 
oxygen molecule to produce alcohol and water (Figure 4.2) (Guengerich 2007). In the P450 catalyzed 
substrate oxidation, the double bond of molecular oxygen is broken stepwise (Steps 4-6). One oxygen 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Enzymatic Role of Target Proteins in Ecdysone Biosynthetic Pathway 
The figure taken from Brown et al (Brown et al. 2009) 
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atom is protonated to form a water molecule (Step 5-6), and then another is used to oxidize the 
substrate (Step 9). One cycle consumes 2 electrons, which are usually supplied by NADPH via P450 
reductase. P450 promotes formation of a highly active oxygen radical FeO3+ [Fe (IV)=O•] and shields 
it from bulk water in order to prevent production of H2O2, a potent carcinogen. 
 
4.1.2. P450 Superfamily 
The cytochrome P450 superfamily is a large group of heme-thiolate enzymes (Gillam 2008). P450s 
have diverse characteristics in terms of hydrophobicity, subcellular localization, or catalytic function. 
For instance, they are localized in mitochondria, microsome (fragmented smooth endoplasmic 
reticulum), or in both organelles (Anandatheerthavarada et al. 1999). They catalyze a variety of 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2. Catalytic Cycle of P450 Catalyzed Monooxygenation 
Oxygen double bond is broken stepwise (Steps 4-6) and one atom is protonated to form a water 
molecule (Steps 5-6), and another is used to oxidate substrate (Steps 9).  
Adapted from Guengerich (Guengerich 2007) 
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reactions from hydration to ring formation (Gillam 2008; Isin & Guengerich 2007). Most of these 
reactions are oxidation catalyzed by FeO3+ formed by the iron ion of the heme group and an oxygen 
ion extracted from molecular oxygen (Isin & Guengerich 2007). 
  
P450s share modest sequence homology, but exhibit high structure similarity. The P450 molecule is 
divided into two domains, alpha and beta. The α−domain is the hydrophilic catalytic domain that 
contains a heme group. The β-domain is the transmembrane domain (Johnson 2003). These domains 
are linked by a proline-rich linker/hinge region, which may contain a “PPGP” motif, said to be a 
crucial sequence for proper folding (Gillam 2008; Kemper 2004).   
 
4.1.3. General Approach to P450 Structure Determination 
4.1.3.1. Construct Engineering  
As many eukaryotic P450s are functional without the membrane anchor, the N-terminal region is often 
either truncated or substituted with a hydrophilic sequence to achieve high yield (Stark et al. 2008) 
and to enable detergent-free purification for biochemical and structural studies (Gillam 2008; Rowland 
et al. 2006). Care must be taken to 
leave the proline-rich region intact, 
as its removal is found to be 
detrimental to proper protein folding 
(Gillam 2008).   
 
Among several expression systems, 
the combination of vector pCW in 
E. coli DH5α cells was the first 
successful heterologous system to 
produce functional eukaryotic P450s 
 
BamHI NdeI 
2 x tac 
Hind III 
PstI 
AccI Amp 
lacZ 
EcoRI 
M13 Ori 
Terminator 
pCW 
Multiple 
cloning sites 
Figure 4.3. Schematic Diagram of the Vector pCW 
 
Adapted from Ogawa et al (Ogawa et al. 1997) 
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(Gillam 2008). Since then the system has been successfully used for biochemical studies (Helvig et al. 
2004; Vail 2005).  The vector pCW was specifically engineered for the expression of enzymatically 
active eukaryotic P450 (Barnes 1993). The vector has some features that promote functional 
expression (Figure 4.3). A cassette of two tac promoters (orange arrow) slows down the transcription 
to facilitate proper folding. The lac Iq gene tightly regulates the expression. A strong trp A 
transcription terminator delays the mRNA degradation, enhancing translation level (Barnes 1993; 
Barnes et al. 1991). Although the vector is widely used, it is not commercially available.  
 
4.1.3.2. Expression 
Numerous case studies are available regarding effective methods of P450 expression using pCW 
system. There are some common features as well as variations to optimum expression conditions. 
Some common features of these methods are: Terrific Broth, growth media supplements such as trace 
elements and thiamine, incubation temperature between 28 ℃ to 32 ℃ (Michael P. Pritchard 2006). 
However, the shaking speed and duration of expression differs considerably. Some P450s are 
expressed slowly at 190 rpm for up to 48 hours (Wu et al. 2006) or fast at 350 rpm for 16 to 20 hours 
(Gillam 1998; Josephy & Logan ; Yim et al. 2005). Addition of a heme precursor 5-aminolevulinic 
acid hydrochloride (ALA) is not essential, but it may increase yield (Gillam 1998). These studies 
suggest individual growth conditions require optimization (Vail 2005). 
 
4.2. Aim 
The aim of the project was to determine the structures of four pairs of insect P450s, spo, phm, dib, and 
sad from D. melanogaster and B. mori by construct engineering. They are all involved in the 
biosynthesis of insect steroid ecdysone. As their substrates are structurally and chemically similar, 
structure determination would shed a light on the structural basis of ligand recognition by P450s. 
Unfortunately no expression was observed from the constructs made. This chapter documents the 
steps that were taken to clone and carry out expression trials of the P450 enzymes.
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4.3. Materials and Methods 
The genes coding for spo, phm, dib, sad from D. melanogaster and B. mori were generous gifts from 
Prof. Kataoka of Tokyo University. The pCW vector was a kind gift from Dr. Mark J. I. Paine of 
Liverpool school of Tropical Medicine. All primer was synthesized by Eurofins MWG GmbH. KOD 
Hot Start DNA Polymerase was from Toyobo. AccuPrime™ Pfx, E-Gel® 1.2 % with SYBR Safe™, 
DNA T4 lygase, E. coli strains DH5α competent cells, and calf intestinal alkaline phosphatase were 
from Invitrogen. All restriction enzymes and 1kb DNA ladder were purchased from New England 
BioLabs (NEB). Both Promega and Quiagen’s Gel and PCR Clean-Up System and Miniprep DNA 
Purification System were used. Rapid DNA Ligation Kit was from Roche. Hybond-P, Amersham ECF 
Western Blotting Agent, Bact Tripton (with salt), Bact Yeast Extract were purchased from GE 
Healthcare. NuPAGE® Novex 4 - 12% Bis-Tris Gel, SeeBlue® Plus2 Pre-Stained Standard, His 
tagged Protein standard were from Invitrogen. Tetra-His antibody, BSA-free was obtained from 
Quiagen, and anti-mouse IgG (Fab specific)–peroxidase antibody and lysozyme were purchased from 
Sigma-Aldrich. Ampicilin sodium salt and IPTG were from Melford. LB Broth was from VWR. All 
other chemicals, including 5-aminolevulinic acid hydrochloride (ALA), were purchased from Sigma-
Aldrich. 
 
4.3.1. Construct Design 
The general scheme of cloning was to substitute the N-terminal membrane anchor region with a short 
hydrophilic sequence “MAKKTSSKGKL” and add His4-tag at C terminus as described by Poulos 
(Poulos 2007) as this has been the most successful strategy employed to solve structure of eukaryotic 
P450s. 
Sequence analysis was performed using the Drosophila proteins as a probe against all non-redundant 
PDB deposited sequences using blast 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&PAGE_TYPE=BlastHome) (Altschul et al. 
1990) and analysed with ClastlW2 (http://www.ebi.ac.uk/Tools/clustalw2/index.html) (Waterhouse et 
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al. 2009) (Thompson et al. 1994; Waterhouse et al. 2009). The identified sequences were realigned 
after addition of either Bombyx homologue sequence or all other target gene sequences. The gene 
sequences of homologous pairs were aligned to identify proline-rich region and “PPTG” motif using 
T-coffee (http://tcoffee.vital-it.ch/) (Notredame et al. 2000) N-terminal truncation sites were decided 
based on the analysis. The N-terminal hydrophilic sequence “MAKKTSSKGKL” and a C-terminal His4 
tag were introduced to the coding sequence of target genes using PCR. Initially a one-step reaction 
was performed using the following generic primer. 
 
5’ primer:  
5’-TACATATGGCGAAGAAAACCAGCTCTAAAGGCAAGCTGCTGXXXXXXXXXXXXXXXXX -3’ 
3’ primer:  
5’ CATGTCTAGATTAGTGATGGTGATGXXXXXXXXXXXXXXXXXX -3’ 
 
If the one-step PCR failed, the N-terminal overhang sequence was introduced in two steps. The first 
PCR added the C-terminal “SKGKL” fragment of the sequence and then the second PCR added the N-
terminal fragment “MAKKTS”. The first PCR used the primers with the following sequence, and the 
second PCR used the same primer as the one-step PCR. 
 
5’ primer:  
5’- CATGACTAGTTCTAAAGGGAAGCTCXXXXXXXXXXXXXXXXXX -3’ 
3’ primer: 5’ CATGTCTAGATTAGTGATGGTGATGXXXXXXXXXXXXXXXXXX-3’ 
 (The sequences in bold are restriction sites, in underlined italic are the hydrophilic N-terminal sequences, and 
in bold italic are 4xHis sequences.) 
 
The PCR was performed using either Accuprime or KOD DNA polymerase according to suppliers’ 
instructions. The reaction mixture was set up with a template-insert mass ratio of 1:1 and 1:5. The 
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DNA concentration of each PCR product was semi-quantitatively measured on a gel, and the products 
were purified using the PCR cleanup kit following the suppliers’ instructions. The purified PCR 
products were stored at -20 ℃ until use. 
 
4.3.1.1. Ligation and Transformation 
As the vector contained a coding gene of a native E. coli protein chew (18 kDa), the multi-cloning site 
of the vector was sequenced to confirm the remaining restriction sites. The vector and PCR products 
were digested with Nde I/Xba I for 2 hours at 37 ℃ using either 20 or 40 units each restriction 
enzyme per 50 µl total reaction volume. The digested and purified inserts were cloned into the vector 
at Nde I/Xba sites using Rapid DNA ligation kit according to the supplier’s direction with a vector-
insert mass ratio of 1:1 and 1:5. Then ligation products were used to transform E. coli DH5α 
competent cell using either 25 or 50 µl competent cells. After 30 minutes incubation on ice, cells were 
heat shocked for 30 seconds at 42 ℃. Cells were then incubated for either a half hour or one hour in 
LB media at 37 ℃, 1, 000 rpm. Then the cells were centrifuged at top speed for 1 minute to remove 
excess growth media. Resuspended cells were plated on LB agar plate with 100 µg/ml of ampicilin 
and incubated at 37 ℃ for overnight. 
 
4.3.1.2. Construct Screening 
The generated colonies were analysed by colony PCR to examine whether they carried the insert. The 
colony PCR reaction mixture stock was prepared and stored at -20 ℃ until use. 1 ml mixture 
contained 100 µl of 2 mM dNTPs, 100 µl of 10x buffer, 60 µl of 25 mM MgSO4, 5 µl of KOD DNA 
polymerase, and 50 µl each of primers that bind to either upstream or downstream of the cloning site.   
 
The sequences of the primers are: 
 5’ primer: 5’- TCACTCATTAGGCACCCCAG -3’ 
3’ primer: 5’ – TAGGCGTATCACGAGGCCCT -3’ 
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Individual colonies were transferred to 10 µl aliquots of the PCR mixture using a sterilized toothpick. 
The colony PCR was performed according to the supplier’s direction to investigate whether the gene 
of interest was cloned into the vector. PCR products were run on a gel and visualized by UV. Only 
colonies exhibiting a product of 1.5 kb band (expected insert size) were selected for further screening. 
An ID number was given to individual colonies by either directly writing on the plate, or by 
transferring colonies to a grid-lined ID plate by toothpick during PCR reaction set up.  
 
Once the presence of an insert was confirmed by colony PCR, construct expression plasmid was 
harvested and subjected to diagnostic digestion in order to confirm the insert was ligated in correct 
direction. Vector was digested at unique restriction site in the vector and at unique restriction site 
within a coding region as an additional confirmation. Sequencing was performed on selected 
constructs to examine whether N-terminal hydrophilic sequence and His4 tag were cloned into them.  
 
4.3.2. Expression Screening 
Generated constructs were introduced into E. coli DH5α cells to test expression. The expression of 
chew protein was used as a positive control to check whether the expression conditions were working 
since various new expression conditions were introduced throughout the screening. A total of five 
small-scale expression experiments were performed using the DH5α strain. The expression 
experiments were repeated with different host strains, BL21(DE3)pLysS, BL21(DE3)C43, and 
Rossetta with the same condition as the fourth expression experiment using DH5α (Table 4.1). 
 
4.3.2.1. Growth Conditions 
As shown in Table 4.1, inoculation OD600, incubation duration, growth temperature, shaking speed, 
and media supplements were varied at each experiment to bring about detectable level of expression. 
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The conditions were based on the reported growth conditions of eukaryotic P450s (Josephy et al. 
2001; Rowland et al. 2006; Wester et al. 2002). 
Growth culture was set up as flows: Terrific broth (TB) supplemented with ampicilin 100 µg/ml final 
concentration was aliquoted in either 50ml Falcon tubes or 500 ml Erlenmeyer flask. 1L Terrific Broth 
was made by dissolving 15 g trypton, 24 g Yeast Extract, 4 ml glycerol dissolved in 900 ml de-ionized 
water. The media was autoclaved and potassium buffer (pH 7.4) at 0.1 M final concentration was 
added to the autoclaved media after it was cooled to room temperature. The growth media was 
inoculated with 1 % overnight culture and incubated until it reached the appropriate OD600. Various 
supplements, such as thiamine hydrochloride (1 mM), trace element cocktail (250 µl per 100 ml) and a 
heme precursor ALA (0.5 mM), were added to the culture at various stages indicated in the Table 4.1. 
100 ml trace element cocktail (Josephy & Logan) contained 3.7 g FeCl3•6H2O, 0.13 g ZnCl2, 0.2 g 
CoCl2•6H2O, 0.2 g Na2MoO4•2H2O, 0.09 g CaCl2, 0.13 g CuCl2•2H2O, 0.05 g H3BO3, and 10 ml 1 M 
HCl. Expression was induced by the addition of IPTG to a final concentration of 1 mM at appropriate 
OD600 reading. Expression trials 1 - 3 used overnight culture of plate-maintained colonies as a starter 
culture, and the trials 4 - 5 used an overnight culture of freshly transformed colonies. 
 
Growth 
Conditions 
Temperature 
(℃) RPM Culture Media 
  
Inducti
on OD 
Duratio
n (hr) 
Inocul
ation 
Expre
ssion 
Inocu
lation 
Expre
ssion 
Vol. 
(ml) 
+Thiami
n  
+Trace 
Element +ALA  
1
1 
3.0-
3.5 16 37 30 225 190 5 N N N 
0.6-
0.9 45 37 30 225 190 5 N N N 
2
2 
0.8-
0.9 45 37 30 225 190 5 N N N 
3
3 0.8 24 30 30 220 350 5 Y Y Y 
0.8 16 30 30 225 350 100 Y Y Y 4
4 
5 0.7 16 30 30 225 350 100 Y Y N 
6
5 
0.7-
0.9 20 37 37 200 200 100 Y Y Y 
Table 4.1.  Expression Condition Sets 
The tested growth condition at each experiments were highlighted in bold font. 
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4.3.2.2. Fractionation 
Cells were harvested by centrifugation at 3, 000 × g for 10 minutes at 4 ℃. Cell pellets were washed 
in 10 percent culture volume of either TSE buffer (200 mM Tris acetate, pH 8.0/ 500 mM sucrose/ 1 
mM PMSF/ 1 mg/ml lysozyme) or phosphate based buffer (20 mM KPi, pH 7.4/ 20 % v/v glycerol/ 1 
mM PMSF/ 2 mM DTT/ 1 mg/ml lysozyme) and centrifuged at 3, 000 × g for 10 minutes at 4 ℃. 
When not used immediately the cell pellet was stored at -80 ℃ until use. When the pellet was frozen, 
it was thawed at room temperature before proceeding to the next step. Pellets were resuspended in the 
same volume of the same buffer and incubated on ice for 1 hour to remove cell wall. The resulting 
spheroblasts were pelleted by centrifugation at 5, 000 g for 10 minutes at 4 ℃. The pellet was 
resuspended in 20 % of the original culture volume of lysis buffer  (0.5 M KPi, pH 7.4/ 20% v/v 
glycerol/ 0.5 mM PMSF/ 1 mM DTT). The cells were lysed by sonication (6 to 8 × 30 seconds pulses 
at 20 – 25 % of maximum power) until lysis solution lost its viscosity. Throughout the wash, 
resuspension, and lysis, samples were kept on ice. The lysate was centrifuged at 5, 000 × g for 10 
minutes at 4 ℃ to remove unbroken cells. If the supernatant was turbid, it was further centrifuged at 5, 
000 × g for 5 minutes at 4 ℃. An aliquot of supernatant (whole cell fraction) was further centrifuged 
at 100, 000 × g for 1 hour at 4 ℃ to fractionate it into cytosolic fraction (supernatant) and membrane 
fraction (pellet). 
 
4.3.2.3. Protein Detection Methods 
Fractions were analysed by SDS-PAGE and Western Blot using chew protein as a positive control. As 
we did not know whether chew protein was His tagged, we used His tagged Protein Standard as a 
positive control for Western Blot. Samples mixed with 4X sample buffer were loaded on to 
NuPAGE® Novex 4 - 12% Bis-Tris gels along with either SeeBlue® Plus2 Pre-Stained Standard (for 
Coomassie staining) or His tagged Protein Standard (for immunodetection). SDS-PAGE and Western 
Blot were run according to the supplier’s direction. For easy comparison, usually two gels were run in 
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parallel, and one was Coomassie stained and another was transferred to Hybond-P membrane for 
Western blot. The primary antibody for the immunodetection was anti-His4 antibody and the signal 
was amplified using the secondary antibody anti-IgG (Fab specific)–peroxidase. Blocking, antibody 
incubation, and detection reagent incubation were carried out according to supplier’s manual with the 
following specification. The membrane was blocked with 5 % non-fat dried milk PBS-T or TBS-T for 
one hour at room temperature on an orbital shaker. Membrane was washed and incubated with 2, 000-
dilution of His4 antibody overnight at 4 ℃ in a 50 ml Falcon tube. After the wash, the membrane was 
incubated with 4, 000-dilution (twice that of primary antibody) of anti-mouse IgG (Fab specific)–
peroxidase antibody for one hour at room temperature on an orbital shaker. Finally the membrane was 
incubated with 5 ml detection reagents, and visualized using the UV-VIS detector LAS3000 (Fuji 
Film). 
 
The optimum dilution of primary antibody was determined as follows: Six pairs of His-tagged Protein 
Standard and a sample were run on a gel, transferred to membrane, blocked and cut into six strips. The 
strips underwent the same previously described procedure until incubation with primary antibody. The 
strips were incubated in a small sealed plastic bag containing 1 ml of 1, 000-, 2, 000-, 4, 000-, 8, 000-, 
16, 000-, or 20, 000-dilution primary antibody. Then after the wash, they were incubated with 
secondary antibody with the twice the primary antibody dilution.  
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4.4. Results and Discussion 
4.4.1. Insert Design 
The basic construct design was similar to the one used by Rowland et al to determine the crystal 
structure of human P450 2D6 (Rowland et al. 2006). This involved replacing the N-terminal amino 
acids prior to the proline rich region with the sequence “MAKKTSSKGKL”. The decision of where to 
truncate the protein was made difficult by the sequence variation in this proline rich region amongst 
the different proteins. Although all target proteins contain a proline-rich region, only the phm proteins 
had the complete “PPGP” linker motif that is observed in P450 2D6 (Figure 4.4). In the spo proteins 
and dib from D. melanogaster the motif was reduced to an “xPGP” motif. Although the “xPGP” motif 
was observed in sad from Drosophila, it was in the N-terminal variable region, which was missing 
completely in the Bombyx protein. We decided to truncate the N-terminal region of all proteins except 
the sad proteins before the “xPGP” sequence. The N-terminal domains of the sad proteins were 
truncated before a proline-rich region of D. melanogaster and the comparable region in B. mori. The 
products from the PCR reactions were cloned into the NdeI/Xbal sites of pCW. The cloning was 
successful in generating constructs for five out of the eight target genes. The constructs generated 
were of D. melanogaster spo and dib, B. mori spo, dib, and sad.  
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Figure 3.4.  Sequence Comparison of Bm & Dm Pairs and Presumed Membrane Anchor 
Region 
A.  Degree of Sequence Similarity: high>red>orange>yellow>yellow-green>low. Lined 
region: deleted region; blue arrow: xPGP motif. 
B. Sequence at N-terminal Region. Double line: presumed membrane anchor region, red: 
PPGP motif; purple: XPGP motif.  
Bm spo: deletion 1-42 
MSSLIIVFFVFALAVYKLLRRKTERWVKT
NKYGGVETAILRTAPGPVCWP IIGS 
 
Dm spo: delation 1-54 
MLAALIYTILAILLSVLATSYICIIYGVKRR
VLQPVKTKNSTEINHNAYQKYTQAPGPRP
WPIIGNLHLL DRYRDS 
Bm phm: deletion 1-27 
MDLYFIWLVT FVAGFWIFKK 
IKEWQNLPPGPWGLPIVGYL PF 
 
Dm phm: delation 1-48 
MSADIVDIGHTGWMPSVQSLSILLVPGAL
VLVILYLCERQCNDLMGAPPPGPWGLPFL
GYLPFLDARAPH 
Bm dib: deletion 1-48 
MFVRLTVKNN IPYRARKCVY 
RRASENFVGS EHASKVNEQG 
DNLMNFEDIPGPRSYPIIGTLH  
 
Dm dib: delation 1-23 
MLTKLLKISCTSRQCTFAKPYQAIPGPRGP
FGMGNLYNYLPGIGSYS 
Bm sad: deletion 1-37 
MHRFPSMSSIRSAVRSRNSNRCSMSTKPH
KSLRTIDEMPHKKSLPIIGTK  
 
Dm sad: delation 1-58 
MTEKRERPGPLRWLRHLLDQLLVRILSLS
LFRSRCDPPPLQRFPATELPPAVAAKYVPI
PRVKGLPVVGT LVDLIAAGGA 
B A 
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4.4.2. Expression Screening 
As shown in Table 4.1, protein expression was attempted using a variety of conditions. Expression 
levels were evaluated using gels stained by Coomassie or by Western blotting. Better or poor aeration 
had no effect. Neither reduced induction temperature to facilitate proper protein folding nor increased 
temperature to increase expression level had any effect. Addition of trace elements or heme precursor 
did not change the situation. Change of host strain had no effect. Since expression of chew protein was 
inducible, non-optimum expression condition is not likely the cause of null expression. 
 
Our strategy was to apply commonly used construct designs to all target proteins one by one to 
maximize the possibility of successful cloning. As no construct expressed target protein, we 
scrutinized the sequence of the modified N-terminal region in order to improve construct design. The 
second codon for Ala is the most prevalent “GCG”. It was later discovered the codon was listed 
among the group of “unfavourable” codons at the second position in the patent application of the 
vector pCW (Barnes 1993). The application mentioned “GCT” (Ala) and “AAA” (Lys) are 
particularly preferred for the second codon to obtain expression in E. coli. This is based on the 
observation that many E. coli genes contain “GCT” at the second codon (Stormo et al. 1982). 
However, recent study of human P450 1A2 found the protein was expressed almost equally well 
regardless of the codon usage at the second position (Kim et al. 2008). Then this may not be the cause 
of null expression. It has been noted that although at least six types of construct designs had been 
developed to date, their mechanism of P450 expression enhancement is still poorly understood 
(Gillam 2008). 
 
4.5. Conclusion 
It was apparent that the strategy used was not optimum for the target P450 expression. The next step 
would be to redesign the constructs using other strategies. At this point in time it was decided to 
concentrate on the other projects. 
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THE USE OF ANTIBODIES IN  
MEMBRANE PROTEIN CRYSTALLIZATION: 
MEMBRANE SPANNING 
AND 
C-TERMINAL CYTOSOLIC DOMAINS 
OF HUMAN ERYTHROCYTE BAND 3
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5.1. Introduction 
As mentioned in the outset, one of the problems with the crystallization of membrane proteins is 
that they have relatively few polar residues on their surface. Good crystal packing requires a 
sufficient number of stable crystal contacts to link the protein molecules in three dimensions. 
Stable crystal contacts involve mainly polar residues, as polar bonds, such as ionic and hydrogen 
bonds, are stronger than hydrophobic interactions. One method for increasing the polar surface of 
membrane proteins is to bind antibodies or synthetic binders to them. These antibodies and 
synthetic binders are selected for tight binding and their ability to enhance crystallization. For this 
reason, they are sometimes called crystallization chaperones (Kossiakoff & Koide 2008; 
Sennhauser & Grutter 2008). The structure determination of cytochrome C oxidase (COX) is the 
earliest application of this approach in membrane protein crystallization (Hunte & Michel 2002; 
Iwata et al. 1995; Ostermeier et al. 1995). In the resulting structure of the COX: Fab complex the 
crystal contacts are solely mediated by antibody Fab fragments. Since then antibody Fab 
fragments have been used to elucidate crystal structures of a potassium channel (Zhou et al. 
2001b), voltage-dependant potassium channel (Jiang et al. 2003), and H+/Cl- exchange transporter 
(Jayaram et al. 2008). 
 
5.1.1. Molecular Architecture of Antibody and Its Use in Crystallization 
As shown in Figure 5.1 (Adapted from a figure on the webpage of NFCR Center for Therapeutic 
antibody Engineering, URL: <http://research4.dfci.harvard.edu/nfcr-ctae/research/index.php>, 
access date: June 1, 2009), an intact antibody is a Y-shaped molecule consisting of two Fab 
fragments as arms coming off of a central Fc stalk. The epitope recognition site is situated at the 
tip of the Fab fragment. An antibody is made of two peptide chains, heavy chain and light chain, 
which are linked by 3 disulfide bonds. Both chains have constant regions and variable regions. The 
definitive terms constant and variable refer to their sequence in comparison to the other 
antibodies; the sequences of constant regions are class dependent. Commonly only a part of the 
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antibody is used for crystallization, as the 
flexible hinge region that links the Fab with 
the stalk of the antibody molecule 
potentially hinders crystallization. By 
cleaving the antibody with papain the protein 
can be split into two Fab fragments and a Fc 
fragment. The Fab fragments contain the 
antigen-binding site but are more rigid than 
the intact antibody. 
 
A Fab fragment is made of a heavy chain and 
a light chain linked by a disulfide bond. The 
structure of Fab fragments from the same 
antibody class are similar, as the sequence of 
constant region (CH and CL) is class 
dependent and highly constant. The structure 
of variable regions has some features unique 
to each antibody due to sequence variability. 
The structurally most divers region is the epitope-binding pocket at the tip of the variable region. 
Another part of the antibody that is often used for crystallization is the Fv fragment. This is the 
antigen-binding half of a Fab fragment. It consists of only variable regions of antibody, VH and LL. 
They are commonly produced as a single recombinant peptide (scFv) of variable regions, as heavy 
and light chains of Fv are more difficult to fold together than Fab (Little et al. 2000). In some 
cases, disulfide bond is introduced to enhance the structural stability (Reiter et al. 1996).  
 
Antibody-assisted crystallization has evolved from simply being means to enlarge the polar 
surface area of the proteins to a method of reducing the flexibility of membrane proteins (Blois & 
Figure 5.1.  Schematic Molecule 
Structure of Antibody  
VH: heavy chain variable region; VL: 
light chain variable region; CH1-3: heavy 
chain constant regions; CL: light chain 
constant region.  
 
The region circled in red is the Fab 
fragment. Recombinant single chain Fv 
fragment contains the region circled in 
blue. The pocket bound to antigen is 
epitope-binding site. The region pointed 
by red arrow is the hinge. The figure is 
adapted from Web Page of NFCR Centre 
for Therapeutic Antibody Engineering 
(Access date: June1, 2009) 
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Bowie 2009). Structure determination of β2 adrenergic receptor (β2AR) epitomizes these 
advantages of antibody-assisted crystallization. The main contribution of the Fab was to mediate 
crystal contacts. In addition the Fab was chosen for its ability to stabilize a single conformation of 
a protein. The flexible third intracellular loop (ICL3) of β2AR had been implicated as a possible 
hindrance against crystallization. The researchers screened Fab fragments for stabilization of two 
helices linked by ICL3 (Day et al. 2007; Kobilka & Schertler 2008; Rasmussen et al. 2007). The 
solved structure shows the selected Fab locked the two helices by binding to the N- and C-terminal 
ends of the native ICL3 (Kobilka & Schertler 2008). Although the binding could not stabilize the 
whole molecule, their successful structure determination highlights the potential of this approach. 
 
  The advantages of Fab assisted crystallization are its universal applicability, limited structure 
alteration of target protein, and its usability for phase determination. An antibody can be 
generated against any protein without any detailed biochemical knowledge. Compared to the 
deletion/fusion approach employed for β2AR structure determination, the use of antibodies in 
crystallization may alter the structure less, as the antibody can recognize a native conformation 
of the epitope (Lefkowitz et al. 2008). The structure of the antibody can also assist in the 
phasing problem since the Fab fragments may be located with the use of molecular replacement. 
In favorable cases the phase information obtained from this may be sufficient to solve the 
structure, eliminating the time consuming step of searching for heavy atom derivatives. The 
structure of a Fab fragment itself is easily determined by molecular replacement with other Fab 
structures as they have high structural similarity because of the shared CH, and CL regions.  
 
The use of Fab fragments in membrane protein crystallization has been limited because of the cost 
and time involved in generating suitable monoclonal antibodies (mAb). The underlying cause is 
the difficulty in generating mAbs suitable for crystallization. The mAbs for crystallization should 
bind to a conformation-sensitive epitope, rather than a linear epitope, such as an extended loop 
(Mancia et al. 2007). This type of mAb only binds to the folded protein in a particular 
conformation. The Fab used for β2AR structure determination was carefully selected for this 
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characteristic (Day et al. 2007). However, this type of mAb is difficult to generate for detergent 
solubilized membrane proteins, as the detergent micelle covers most of the membrane protein 
surface and often only loops protrude above the micelle. This could lead to generating antibody 
that binds indiscriminately to both native and denatured protein. Now a few techniques have been 
developed to aid antibody production such as budding baculovirus display (Saitoh et al. 2007) and 
phage display (Rothlisberger et al. 2004). Further advancements in these approaches could 
broaden the use of Fab to assist crystallization.  
 
5.1.2. Model Protein: C-terminal Domain of Human Erythrocyte Band 3 
Band 3, also know as human erythrocyte anion exchanger (AE1), is composed of an N-terminal 
cytosolic domain, a membrane-spanning domain, and a C-terminal cytosolic domain. (Often in 
the literature the membrane spanning and C-terminal cytosolic domains are referred to as the C-
terminal domain.) The N-terminal domain contributes to the maintenance of plasma membrane 
integrity as an anchor for cytoskeletal protein network via ankyrin (Maier et al. 2009). The 
membrane-spanning domain transports bicarbonate anions (HCO3-) in exchange for Cl- ions. The 
N-terminal and C-terminal cytosolic domains provide binding sites for many cytosolic enzymes, 
including haemoglobin, carbonic anhydrase II, glycolytic enzymes, hemoglobin, and kinases 
(Alper 2006; Perrotta et al. 2005). 
 
As an anion transporter, Band 3 is one of the essential proteins involved in respiration and 
homeostasis of extracellular pH. Band 3 plays an important role in the removal of CO2 from the 
peripheral tissue, as HCO3- ion is the major chemical form of the waste CO2 gas transported to 
the lung. In peripheral tissues, waste CO2 diffuses into the erythrocyte cytosol, where it is 
converted to HCO3- by cytosolic carbonic anhydrase. The HCO3- ion is then transported from the 
cytosol to blood by Band 3 to be transported to the lung. In the lung the process is reversed. Band 
3 transports HCO3- from blood back into the erythrocyte cytosol to be converted to CO2 gas. 
CO2 then diffuses into blood out of the body. The overall effect is that the CO2 transport 
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capacity of the blood is greatly enhanced by Band 3. 
 
 The membrane-spanning and C-terminal domains have eluded crystallization, although the 
crystal structure of the N-terminal domain (residue 1-379) was determined at a resolution of 3.6 Å 
nearly 10 years ago (Zhang et al. 2000). The membrane-spanning domain is predicted to contain 
12 - 14 transmembrane (TM) helices, which are linked with short or long loops (Figure 5.2). 
The proposed transport mechanism suggests subdomains TM 1-5 and TM13-14 move with 
respect to TM6-8 during the transport cycle (Takazaki et al. 2006). The structure determination 
of the membrane-spanning domain is vital in elucidating its anion transport mechanism.  
 
Drs. Takami Kobayashi and Takuya Kobayashi of Kyoto University, our collaborators in Japan, 
have successfully crystallized the protein after the removal of the N-terminal domain using 
trypsin.  Despite extensive optimization of the crystallization conditions they have been unable 
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K300: Tripsin 
cleavage site 
Figure 5.2. Topology of the Band 3 Membrane Spanning and C-terminal Cytosolic 
Domains 
The transmembrane segments are numbered according to the convention. Adapted from 
Alper (Alper 2006) 
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to obtain crystals that diffract to beyond 5 Å. The aim of this project was to obtain crystals of 
Band 3 diffracting to a higher resolution by co-crystallization with Fab fragments. The primary 
objective of the co-crystallization was to increase the polar surface area to improve crystal 
packing. It would be an additional advantage if binding a Fab fragment could lock the molecule in 
one conformation. The selective binding of inhibitors suggests Band 3 has at least two distinct 
conformations (Takazaki et al. 2006).  
 
Our collaborators have been developing novel mAbs against band 3. They also decided to test the 
suitability of a number of mAbs available commercially for crystallization. In particular BRAC 17 
and BRAC18 are known to bind to 5-6 loop of Band 3 (Smythe et al. 1995). Since these mAbs are 
originally generated for biochemical studies, it is unclear whether they recognize a conformational 
or linear epitope. We received crystals that had been grown in the presence of Band 3 and the 
respective Fab complexes, and these were tested for diffraction. From the diffraction and cell 
dimensions it was evident at this stage that the crystals contained only a Fab fragment. 
Nevertheless a dataset from BRAC18 crystal was collected to aid in the structure determination of 
Band 3, if suitable crystals of Band 3 complexed with BRAC18 could be obtained. 
 
5.2. Aim 
The aim of this project is to determine the crystal structure of an anti-Band 3 Fab fragment BRAC18 
in order to facilitate the structure determination of Band 3: Fab complex in the future.  
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5.3. Materials And Method 
The crystals were shipped from our collaborators in Japan. The purification and preparation of the 
complex was performed by Dr. Takami Kabayoshi and Dr. Takuya Kabayoshi of Kyoto University in 
collaboration with Prof. Hamasaki of Kyushu University. Prof. Hamasaki purified the Band 3 from 
human blood, cleaving off the N-terminal domain with trypsin and deglyosylating with PNaseF. Drs. 
Takami and Takuya Kobayashi prepared the Band3: Fab complexes. The antibodies were purchased 
from the International Blood Group Reference Laboratory (Bristol, UK). Fab fragments were prepared 
by digestion with papain using a Fab preparation kit from Thermo Scientific (Rockford, Il, USA). The 
purified Band 3 C-terminal domain and Fab fragments were incubated overnight at 4 °C, and purified 
by size-exclusion chromatography. 
 
X ray diffraction data of BRAC18 were collected at beamline ID23-2 of the European Synchrotron 
Radiation Facility (ESRF) by Prof. So Iwata of 
Imperial College London. Data processing and scaling 
were performed with the programs Mosflm (Leslie 
1999) and the CCP4 suite (Collaborative 
Computational Project 1994). The crystallographic 
data is summarised in Table 5.1. The crystal belongs 
to the space group P1. The unit cell dimensions are a: 
b: c = 53.0: 69.0: 71.5, and α: β: γ = 99.1 °: 91.5 °: 
108.6 °. 
 
Electron density was calculated by molecular 
replacement using Phaser (McCoy et al. 2005; Read 
2001; Storoni et al. 2004) from the CCP4 suite 
(Collaborative Computational Project 1994). As the 
 BRAC18 
Space Group P1 
Unit Cell Parameters:  
a 53.0 
b 69.0 
c 71.5 
α 99.1 
β 91.5 
γ 108.6 
Solvent Fraction 48.6 
Total Reflections 239574 
Unique Reflections 121681 
Crystal Mosaicity (∘) 0.49 
Resolution Range (Å) 1.58 - 31.42 
Completeness (%) 95.9 
Rmerge (%) 7.6 
MR Search Model 2IPT 
R (%) 19.7 
Rf (%) 23.9 
Table 5.1.  Diffraction and 
Refinement Statistics of BRAC18 Fab 
Fragment Crystal 
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sequence of the Fab was unknown to us, the molecular replacement was run with different models of 
Fabs from the PDB (PDB Accession codes: 2HKH, 2IPT). The best solution was obtained from 2IPT, 
and this solution was refined to determine the BRAC18 structure.  
 
Refinement was performed using Refmac (Pannu et al. 1998) (Murshudov et al. 1997; Murshudov et 
al. 1999; Winn et al. 2001) with manual model building in Coot (Emsley & Cowtan 2004). The initial 
model was refined firstly by rigid body refinement using each chain as rigid bodies, followed by 
restrained refinement where the coordinates were optimized along with the individual isotropic B 
values. In the final cycles TLS refinement (Winn et al. 2001) was carried out with eight TLS groups 
corresponding to the VH, VL, CH, CL domains of the Fab. Water molecules were put in manually using 
Coot (Emsley & Cowtan 2004). Density that was consistent with cysteine residues was also observed, 
and these were included in the final model.  
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5.4. Results and Discussion 
The crystals, which initially were thought to be of the complex between Band 3 and BRAC18, turned 
out to contain only the Fab fragment. The structure of this Fab fragment was determined by molecular 
replacement and refined at a resolution of 1.6 Å to an R-factor of 19.7 percent and a corresponding R-
free of 23.9 percent. The asymmetric unit cell contains two identical Fab molecules, 682 water and 
two cysteine molecules. The Fab molecule consists of a heavy chain (223 amino acid residues) and a 
light chain (212 amino acid residues). As shown in the Figure 5.3, the electron density around 
epitope-binding site was well resolved. 
 
A blast search performed using the elucidated sequences of heavy and light chains against the 
sequences in the PDB identified two sets of antigen-bound Fab structures 1OTS and 2I9L (heavy 
chain), and 1OB1 and 1EGJ (light chain). The analysis showed Ser50 - Ser63 and Thr99 – Ala113 of the 
heavy chain and Ser29 – Thr30 and Ser90 – Phe93 of the light chain are variable regions of BRAC18. It 
has been observed that in vitro, heavy chain is the major contributor to the diversity and specificity of 
antibody while light chain 
fine-tunes or alters the 
specificity (Roitt & Delves 
2001). In agreement with this, 
the regions Ser50 - Ser63 and 
Thr99 – Ala114 of the heavy 
chain are located on the tip of 
two adjacent loops forming a 
pocket, presumably epitope 
recognition site (Figure 5.4). 
Superimposition with antigen-
bound homologous structures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3. Electron Density around Epitope-binding Pocket 
The image was drawn using Coot. 
W111/H P109/H 
S90/L 
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shows BRIC18’s structural deviation from the norm is most extensive around Thr99 – Ala114 of the 
heavy chain.  
 
 
Figure 5.4.  BRAC18 Fab Structure and Comparison with Other Antigen-bound Fab 
A. BRAC18 structure (epitope binding site in red circle) 
B. Antigen binding region of Fab with superimposed homologous structures 
The left hand site chains are antigens. The right hand side top is the light chain, 
and the bottom is the heavy chain of Fab structures. Notice antigen-Fab 
interactions (circled in red) mostly occur at heavy chain. 
C. Front and D. side view of the presumed antigen-binding pocket of BRAC18. 
 
 Figures are drawn using PyMOL and Coot. 
 
B A 
C D 
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5.5. Conclusion and Future Direction of the Project 
The structure of a Fab fragment BRAC18 was determined and refined at a resolution of 1.6 Å with the 
view of utilising the structure to aid in the structure determination of the Band 3: Fab complex. Since, 
even as a complex with a Fab fragment attached Band 3 is unlikely to diffract to high resolution, 
having a well-resolved Fab structure was thought to be useful as a search model to calculate electron 
density map. This project was suspended, and the effort was focused to another more promising 
project, NhaA. 
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